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ABSTRACT 
LYNDA F. BJNEWALD. Biochemical Characterization of Human Thy 1. 
(Unde.r the di rect ion of Dr. An-Chuan Wang.) 
The present studies were undertaken in order to a) verifY the 
presence of a human Thy 1 antigen, b) demonstrate its similarity to 
murine Thy 1, and c) biochemical~ characterize the molecule. 
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Previously, a 25,000 molecular weight molecule had been isolated 
from a human T lymphoblastoid cell line, ~~olt 3, using isolation 
procedures most frequently used for the isolation of rodent Thy 1. The 
human Thy 1 (p25) was demonstrated to be biochemically similar to 
murine Thy 1.2 by molecular weight and ability to bind Lens Culinaris 
lentil lectin. Recently, we confirmed similarity between the murine 
and the human molecule by peptide maps and amino acid compositions. In 
addition, a strong cross-reactivity using ananti-p25 antiserum was 
established with human IgG subclasses. The antiserum did not react 
with human IgM or IgA, nor with primate immunoglobulins or a battery of 
other antigens. Through a variety of immunoabsorption experiments, 
through the use of various digestions, and known amino acid sequences, 
the shared areas of homology were tentatively determined to be in the 
intact disulfide bonds of the first and third domains of human IgG and 
the 9-112 disulfide bond of Thy 1. 
A form of the p25 antigen noted and partially characterized was 
the p40 antigen, the dimerized form of the p25. The p25 and p40 are 
essentially identical in several aspects, such as amino acid 
compositions, peptide maps, carbohydrate compositions , reactivity to 
anti-p25 serum, and in aggregation studies. It ~s determined that the 
iii 
detergent sodium dodecyl sulfate tends to convert the p25 molecule into 
the p4 0 form through some ather chemical means than di sulf ide hond 
interchange. The ~thod of isolation and reagents used unequivocally 
determines observed molecular weight. 
Another form detected is the p16 which also reacted with anti-p25 
serum, was similar by amino acid composition, slightly different hy 
peptide mapping and definitely contained less carbohydrate than the p25 
antigen. ~he p16 is pJssibly a cryptic antigen, a breakdown fonn of 
the p25 molecule. 
A 40,000 M'"W" molecule was isolated from human thymus which binds 
lentil lectin, reacts with antiserun made to the p25 antigen and 
possesses an amino acid composition very similar to that of the p25 
antigen. Data suggests that the Thy 1 antigen from human thymocytes 
tends to dimerize more readily than that found on ~~olt 3 cells and that 
this a Ltigen is present in considerably smaller amounts on human 
thymocytes as compared with Molt 3 cells. 
iv 
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CHAPrER 1 
THE THY 1 MOLECULE 
2 
INTRODUCTION 
The Thy 1 molecule w.as originally described as an antigen on mouse 
t~us and brain cells by Reif and Allen in 1964 (1). In the mouse 
there exists two serologically identified alloantigen~, Thy 1.1 (AKR) 
and Thy 1.2 (C3B) (1). The antigen has proved to be a useful cell 
surface marker for thymocytes and mature T lymphocytes in mice (2). 
The number of antigenic sites per thymocyte was determined to be 
greater than 400,000 for Thy 1.2 (3) and about 600,000 for Thy 1.1 (4). 
The antigenic activity of brain cells is approximately equal to tqymo-
cytes on a packed tissue basis (1). 
Thy 1 was one of the first cell surface differentiation antigens 
to be identified on lymphocytes. The expression of Thy 1 varies during 
different stages of differentiation ~ in mice it is present on 
thymocytes and peripheral T cells but not on bone marrow (2) or 
haemopoietic cells (5). Such is not the case in the rat. The amount 
of antigen on rat and mouse thymocytes and brain is similar as is the 
brain developmental pattern, but most peripheral rat T cells lack the 
antigen. In rats Tqy 1 appears earlier in development than in mice. 
It is present on the pluripotent haempoietic stem cell, early lymphoid, 
(both T and B) and non-lymphoid (megakaryocytes, mast cells, and some 
eosinophils) progeny (4,6-8). Rat Thy 1 possesses the Thy 1.1 
antigenic determinant but not the Thy 1.2 determinant (9). Xenogeneic 
(rabbit) antiserum has been raised which detects a rat specific 
determinant and rat-mouse cross reacting determinants (10). Antigenic 
sites on the Thy I molecule can be divided into determinants specific 
for the Tqy 1 of the immunizing species and determinants which cross-
3 
react between species (11-13). Thy 1 is present extracel1u1arly; in 
association with collagen based connective tissue in bone blood vessels 
in rat lymphoid organs (14). In rodents, fibroblasts (15), some 
epidermal cells (16), breast cells (17), and muscle cells (18) also 
display the Thy 1 antigen. 
Identity of tissue distribution is usually taken as a strong 
indication of homolo~r, but this is not the case for Thy 1. T~ 1 is 
found in similar concentration in canine brain when compared to rodent 
brain, but there are considerably smaller amounts of canine Thy 1 in 
thymus, lymph node, spleen, and bone marrow. Surprisingly, the antigen 
was detected in fairly large amounts in canine kidney Which has not 
been seen in the murine system (13). Unlike the mouse, Thy 1 is not a 
marker for T cells in the Syrian hamster but is also expressed on the 
majority of resting, peripheral B cells (19). In the chicken a 25,000 
molecular weight molecule has been isolated from brain and is assumed 
to be the Thy 1 molecule but cannot be detected on chicken thymus (20). 
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SEROLOGY AND LOCATION OF THE THY 1 MOLECULE IN THE HUMAN 
Thy 1 is expressed in large quantities in the grey matter of the 
cortex and basal ganglia of human brain and lower quantities in white 
matter of cerebrum and peripheral nerves (21). Little controversy, if 
any, exis ts concerning Thy 1 in human brain, however, contradict ions 
exist in the literature concerning the location of Thy 1 in human 
thymus (22-24). 
Originally Tqy 1 was not detected at all in human tbymocytes 
(13,25), although easily detected on human brain in amounts similar to 
murine Thy 1 using cross-react ing ant ibodies to rat Thy 1. None was 
detected on various organs and tissues at that time. McKenzie and 
Fah re (26) detected human Thy 1 only in discrete area s of the thymus, 
spleen, and lymph nodes but not on peripheral blood lymphocytes using 
an antiserum prepared against a human brain Tby 1 antigen. Cross-
reacting determinants were discovered on hunan fibroblasts and hunan 
brain by t he use of a rabbit anti-rat Thy 1 and by monoclonal anti-
bodies to human brain Thy 1 which also reacted with human fibroblasts 
(27 ) • 
In contrast, Balch and Ades (28) using an antiserum prepared 
against a 25 ,000 rlolecu1ar weight antigen isolated froI"Q f10lt 3 cells, 
noted that t he p25 antigen was preferentially expressed on peripheral T 
lymphocyte s and not on brain tissue. They also used an antiserum which 
recognized a 25,000 MW membrane antigen, that was prepared against 
monkey tl~rmocytes, to localize the antigen on normal human T lympho-
cytes and human T lymphoblastoid cells (29). 
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Sagi and Tanigaki (30) isolated and prepared a rabbit antiserum to 
a glycoprotein from a cultured leukemic T cell, Molt 4. This antiserum 
reacted with a T~ I-like glycoprotein isolated from a T leukemic cell, 
SKW-3. Reactivity to their antiserum was widely distributed in all 
human organs and tissues but predominated in brain and testis. Thymus, 
spleen, and peripheral blood leuko~te preparations were positive, with 
heart, kidney, liver, and skeletal muscle displaying less antigen. 
Ritter et ale (31) found human Thy 1 present in 0.1-0.5% bone 
marrow cels and 0.2-10% t~us. They found that Thy 1 is confined to 
early stages of T and B lymphocyte development but absent from all 
myeloid cells. Using a rabbit antiserum to rat brain Thy 1 and mono-
clonal antibodies to human brain Thy 1 they also found that all Thy 1 
positive T cells are situated in the outer thymic cortex. 
At this time one can only assume that the controversy arising 
concerning the distribution of Thy 1 in the human is due to the 
methods and materials used for the production of antisera and due to 
the sensitivity of the techniques employed . For example, Ritter et ale 
(31) noted that the FACS (Fluorescein Activated Cell Sorter) gave 
consistently higher values than did fluorescent microscopy. 
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MOLECULAR ST RUCTURE 
There has been considerable disagreement as to the molecular 
nature of the Thy 1 molecule. Some investigators have found various 
sizes for the nolecul e, such as 4 0,000 MW (32) or 60,000 HW (33) but 
the recent general consensus has been a molecular weight of approxi-
mately 25,000 (34-36). Some investigators have suggested it to be a 
glycolipid (37 ,38), Ylhile others have suggested it is a glycoprotein 
(39,40). The present general consensus is that the molecule is indeed 
a glycoprotein (33,41,42) while some question remains concerning the 
presence or nature of a lipid moiety (36) or an association with lipid 
The murine Thy 1 antigen isolated using deoxycholate as a 
detergent has a molecular weight according to SDS-PAGE (sodiuM dodecyl 
sulfate-polyacrylamide gel electrophoresis) of 25,000 (43) as does rat 
Thy 1 isolated from both brain and t1'\Ymocyt es (33,44). Thy 1 from 
canine brain and human brain using the same isolation procedure also 
has a molecular weight of approximately 25,000 (45) as does Thy 1 
isolated from human foreskin fibroblasts (26). Thy 1 isolated from 
human leukemic T cells also seems to have an apparent molecular weight 
of 25,000 daltons (29,46). However, the correct molecular weight has 
been determined by sedimentation equilibriUM studies (35) and for rat 
brain Thy 1 it is 17 ,500 and for rat thymocyt e Thy 1 it is 18 ;roo. 
Part of the molecule is carbohydrate, therefore the charge/mass ratio 
gives an anomalous weight of 25,000 by SDS-PAGE. The molecular weight 
of the polypeptide portion of the molecule is 12,500. The Stokes 
radius of canine (3.0 nm) and human (3.25 nm) brain Thy 1 is similar to 
that for the rat Thy 1 (45). 
The amino acid compositions of the various species of Thy 1 show 
varying degrees of similarity. The Thy 1 molecule is fairly 
hydrophilic in its amino acid composition. Published amino acid 
compositions for various Thy 1 preparations from various tissues and 
species are listed in Table 1. 
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Rat brain Thy 1 was sequenced in 1981 (36) and murine brain Thy 1 
in 1982 (47). These sequences can be seen in Table 2. Sequence 
homology with immunoglobulin was found (48). The rat Thy 1 consists of 
III amino acids with two disulfide bonds from Cys 9 to Cys III and Cys 
19 to Cys 8S. It has three N-linked carbohydrate structures at 
residues Asn 23, 74, and 98. The murine Thy 1.1 possesses an Arg at 
position 89 while in Thy 1.2 there is a G1n. The murine Thy 1 has 112 
residues and is very similar to the rat Thy 1 except for two areas, one 
at sequence 26-29 where there are four differences and a deletion and 
one at residues 63-67 where there are five different amino acids. 
The carbohydrate component has been found to be 20-30% of the Thy 
1 molecule. One group of investigators found marked differences 
between rat brain and rat tnYmocyte Thy 1 carbohydrate compositions 
(34). Galactosamine was found in brain Thy 1 but not in thymocyte Thy 
1 in contrast to sialic acid which was found in much greater amounts in 
thymocyte Thy 1. Given that differences in co~position are likely to 
reflect much larger differences in structure, these investigators 
suggest that the carbohydrate chains of brain and t~mocyte Thy 1 may 
be completely unrelated. All Thy 1 isolated from a homogeneous lympho-
blastoid cell line was demonstrated to bind to lentil lectin (43). A 
comparison of Thy 1 from lymphoma and from normal thymocytes showed a 
heterogeneity of Thy 1 froM normal cells, but not on lymphoma cells 
Published carbohydrate composi-:ions are shown in Table 3. As can 
be seen considerable variability exists. This could be due to 
carbohydrate complexi ty of Thy 1 molecule and also due to the nature of 
the carbohydrate assay accuracy which cannot be compared to the 
accuracy attained by amino acid composition analyses. 
Carbohydrate c ompl exity has also been demonstrated by le ctin 
affinity studies and isoele ctric focus i ng (50). Only 50% of rat 
t hymocyte Thy 1 bO~.l!1d to lentil lectin ( 3h ) a nd the S8J11e was s~own for 
mouse t hy mocyt e !hy 1 (50) while all brain Thy 1 binds to this lectin. 
In addition, 25'0 of mouse thymocyte Thy 1 was shown to bin:! wheat germ 
agglu t inin while 1 0 0% va s bou nd by con ca nav a l in A. Analys is by iso-
electric focusing revealed six charge variants, which after isolation 
and treatment wit:-l neu raJ1'linidase showed that heteroge n eity was du e to 
varJing amounts of sialic acid (SO). Another group of inve s tigators 
found that Thy 1 isolated from iITlP.lature roc:>use thymocytes possessed ~ess 
sialic acid than that isolated from peripheral or mature T lymphocytes 
(51). Therefore on e can assune a considerable degree of heterogeneity 
of the carbohydrate portion of the varjous Thy 1 molecu les. 
Next to the q-llestion of function, the second most often posed 
question is -- ::()w is the Thy 1 molecule anchored in the cell membrane? 
Is there lipid a s s ociation or is lipid covalently linked to the 
molecule? rl' here is no 11Yr drophobic stretch of amino acids in t h e 
sequence of the molecule to form a tail piece or section to extend into 
or through the lipid bila.yer of the cell membrane . Yet , mouse 
thymocyte Thy 1 can be labell~d in membranes by a photo-activated 
reagent which partitions into lipid (52) . 
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Miller and Esselman (38) have suggested that mouse Thy 1 is a 
ganglios ide using experiments showing that Thy 1 cytotoxici ty could be 
inhibited by various ganglios ides . They also snggested it could be a 
glycolipid (53) . In contrast , other i nvestigators have not found Thy 1 
antigenic activity in lipid material (54,55) . It has since been shown 
that Tny 1 is no~ a ganglioside, but a glycoprotein . The molecule can 
only be isolated in the presence of detergent , usually deoxycholate . 
Membrane proteins normCt~ly associated wi th lipid bind large amounts of 
non- ionic or weakly ionic jetergents, whereas other proteins do not 
(56) . The Thy 1 glycoprotein forms a micelle and does not bind to the 
detergent itself (35) . In the absence of DOC, the rat Thy 1 forms a 
large homogeneous complex of approximately 300,000 MW . The complex can 
only partially be dissoc iated by 4!~ guanidir:.um ch:oride s uggest ing that 
the protein portion is not directly involved in the aggregation (35). 
Barclay et al e (34 ) mentions a peak running in identical manner to 
stearic acid during carbohydrate analysis of rat brain Thy 1 . '"While 
sequencing rat brain Thy 1, (',ampbe~l et ale (36 ) could isolatp t r ~ 
terminal peptide either in highly aggregated form or after purification 
in Brig 96 . The peptide appeared to have hydrophobic properties, yet 
did not contain arw extended sequence of qydrophobic amino acids . The 
C-terminal peptide possessed ninhydrin-positive rmterial, gluc.os8....'TIine, 
and galactosamine. They suggest linkage to lipid and site precedents 
in the Ii terature such as linkage through sulhydryl and amino groups of 
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the N-terminal cysteine of Escherichia coli murine-lipoprotein (57) and 
sulhydryl of the C-terminal cysteine of rhodotorucine A of Rhodospori-
diun toruloides (58). But with Thy 1 ltpid could not be at tached 
through the sulhydryl of Cys III because it is bonded to Cys 9. They 
suggest that the carboxyl of Cys III could be the attachment site for 




The gene for Thy 1 is located on chromosome 9 in the mouse (59). 
The rat Thy 1 gene has been cloned and sequenced (60) and the cDNA 
sequence suggests a new and different regulatory mechanism for expres-
sion of the molecule. The DNA sequence ends early at a position 
corresponding to amino acid 103, 8 amino acids earlier than predicted 
from the protein sequence. There is no termination codon, and a pre-
sumptive polyadenylation signal which is part of the coding sequence i s 
found 12 nucleotides upstream from the poly(A) tail. One explanation 
for this observation is that a deletion of the C-terminal coding 
sequence was retained, however this phenomena has never been described 
before. The author's explanation is that the sequence at nucleic acid 
positions 293-298 served as a polyadenylation signal in vivo and posi-
tion 310 which is 12 nuc1eotides downstream served as the polyadenyla-
tion site. Differential poly(A) site selection may control the 
expression of the C-terminal coding segment. 
Levels of Thy-1 expression change dramatically during cell 
differentiation. Crude thymus extract has been shown to cause mouse 
Thy negative bone ma r row and spleen cells to become Thy 1 positive 
(61). Moriuchi et ale (60) suggest that thymic honnones may induce the 
genetic me chanism necessary for the expression of Thy 1. Th~r also 
found nucleotide sequence homology between Thy 1 cDNA and the mouse 
light chain variable region to be 3610. They propose that the Thy 1 
gene may have inherited a remnant of a mechanism involved in gene 
expression, namely differential polyadenylation such as seen with 
membrane and secreted IgM. 
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FUNCTION OF THE THY 1 MOLECULE 
The Thy 1 molecule is a prime exa~ple of a fairly well-character-
ized molecule in search of a function. Its function mlst be fairly 
consistent in brain since a variety of species possess large amounts of 
brain Thy 1 (13). Although originally used as a T cell marker in mice 
the antigen is not equally distributed in thymus or T cells across 
species, therefore function ma.y be different from that in brain. 
Thy 1 cannot be detected in the brain of newborn mice until seven 
days postnatally (62). The antigen increases to adult levels by day 23 
(42). During this time When the bulk of neural development occurs, an 
increase in number of synaptic connect ions clos ely parallels the 
increase in antigenic expression. The antigen appears enriched in 
synaptosonal fractions (63). In brain reaggregate cultures, the 
presence of Thy 1 closely correlates with the appearance of synapses 
(64,65). Therefore, in the brain Tqy 1 has been thought to be 
exclusively associated with synapses (66). Bu.t antibody to Thy 1 
injected into rat hypothalmus selectively inhibits carbamyl choline 
induced drinking (67). This suggests that antibody reaction with Thy 1 
results in blockade of cholinergic function. ~hese experiments 
indica ted that Thy 1 has no association with alpha-adrenergic funct ion. 
Barclay et ale (34) sugges ts that funct ion ray be mediated by 
carbohydrate structures since amino acid compositions between brain and 
thymocyt e Thy 1 were ver:{ similar, "Whereas carbohydrate compos i tions 
were not. The polypeptide chain may anchor t~e mole cul e in the 
me~brane Rnd therefore provide a backbone for the display of different 
carbohydrate ligands. These ligands may be recogn i tion si tes for 
glycosyl transferases or lectins (68). Hoessli et ale (5 1) also 
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sUGgests that carbohydrate f1.mctions in cell-cell canmu.nications since 
T lymphocyt e differentiation is accompanied by an increas e in sialic 
acid content of murine ~hy 1. Neu raminidase-treated periphera: 
lymphocytes do not houe to lymphoid organs when injected intravenously 
into syngeneic hosts but are quickly trapped by the li ver (69). Thy 1 
was also considered to have a role in cell-cell adhesion in studies of 
J11.ap'ullarJ tunor cells in cult ure (70) . Specific interaction of anti-~hy 
1 sera with Thy 1 antigen redirected the differe ilt iation p::ogram of 
these cells. 
Thy 1 may function in mediating selective adhesion of lymphocytes 
to extracellular substrates during recirculation. ~he antigen was 
f ound to be associated with collagen-b~sed connective tissue around 
blood vessels in rat lymphoid organs (14). Thy 1 may not only be 
i nvol vea in se2 e- ~t i ve adh e s ion and nigra t ion of :lot just ly:rnJihocyt es in 
circulation, but a l so of other ~h~f 1 negative cell types . Ritter e~ 
ale (14) suggested a reciprocal relationship between ~~hy 1 on cells and 
on connective tissue. For example, in the rat lymph node and spleen, 
the Thy· 1 pes i":-ive conne~tive tissue is surrounded by Thy 1 negative 
lym}.lhocytes (7 ) . In the P1Ouse, the vascular basei'1ent me mb ranes are Thy 
1 negative, while recirculating ~ ce lls are posi~ive. 
Springer ~_t ale (71) consider's Thy 1 a "j u!'1ping " differentiation 
antigen in contrast to a "lineage" antigen which are expres sed in an 
ontogenetically or flL.Y1ctionally orderly fashion. "Jump i ng" ant ige ns 
will occur on di stantly related tissues while J1'K)re closely relateci 
tissues will not have the antigen. Therefore they have different 
functional properties from lineage antigens. Carbohydrate appears to 
be a prominent structural component of jumping antigens. Another 
striking property of jumping ant igens, such as that of the Forrsman 
antigen, is that the change of antigen expression correlates with 
cellular migration to a different tissue. Adhesive properties also 
change (72). ,Jumping antigens might have similar functions in very 
different tissues. 
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Thy 1 has a direct role not only in normal, but also in neoplastic 
T cell growth control. Support for this is shown by experL~ents using 
anti-Thy 1 antibodies to block Con A induced T cell mitogenesis (73) 
and blockage of T lymphoma cell proliferation (74). Thy 1 can be found 
on leukemic and cancerous cells. Human melanocytes are derived from 
neural crest cells on Which Thy 1 is expressed. Normal melanocytes do 
not express the antigen Whereas melanocytes in certain naevi and 
melanoma do (75). These investigators suggested a role for Thy 1 in 
cell-cell recognition and also stated that detection of the antigen can 
be a prognostic, biological marker for melanoma. They also found many 
Thy 1 positive lymphocytes below the melanomas. Similar results were 
reported for lymphocytes in inflammatory and malignant infiltrates in 
the skin (76) and lymphocytes infiltrating breast carcinoma (77). They 
speculated that either the lymphocytes were beginning to express Thy 1 
or had acquired such from surrounding medium. 
t·1aino and coworkers (78) used a rabbit ant i-mouse brain, which 
precipitated a 25,000 dalton glycoprotein from Thy 1 positive cells, 
but not from Thy 1 negative cells, to activate or initiate T lymphocyte 
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proliferation. Antisera to Thy 1 allo-determinants were neither mito-
genic nor inhibitory to anti-Thy 1 induced responses. Their studies 
suggest a Thy 1 activating determinant, the necessity of an accessory 
cell, and a mobile plasma membrane necessary for interactions of Fc 
receptors, H-2, la, and T200 glycoproteins. 
Sequence homology was found between rodent neuronal Thy I and 
immunoglobulin (47). A lack of alpha-helix and possession of similar 
circular dichroism also suggests that Thy 1 structure resembles an Ig 
domain. When compaied to IgD by circular dichroism both T~ 1 and IgD 
show a negative peak at 217 nrl. The authors suggest that the JOC)lecule 
exists to be recognized (79). Homology with variable domains and 
bet~-rnicroglobulin suggests that Thy 1 may be like the primordial 
immunoglobulin domain and therefore places it in the immunoglobulin 
superfamily. This has led Jensenius and Williams (79) to postulate 
that the Thy I molecule is the T lymphocyte antigen receptor. They 
suggest that the role of the primordial Ig domain was to function as a 
ligand for triggering cell-cell interactions by binding to a 
recognizer, which was not liQ~oglobulin-like and that Thy I may be the 
present day molecule with this function. In support of this function, 
a monoclonal antibody prepared against rat T cells recognizes a 
cross-reactive determinant on Thy 1 and the Vk light chain of the 
TEPCl5 myeloT!la protein (80). These latter findings may imply a role 
for the Thy 1 molecule in antigen and/or mitogen recognition or may 
represent a cross-reaction or no st~~ctural or functional significance. 
In conclusion, theories concerning the function of Thy I include a 
role in cell differentiation, in cell adhesion, in cell migration, T 
lymphocyte recognition, cell activation and therefore cell-cell 
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aData from McClain et al (41). 
b Data from Zwerner et al (42). 
CData from Barclay et al (34). 
dData from McKenzie et 8.1 (45). 
eData from Cotmore et al (27) • 
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Table 2. Amino Acid Sequence of Rat and Monse Thy 1 
10 
Rat Thy 1 
Mouse Thy 1.1 
PCA - ARG - VAL - ILE - SER - LEU - THR - ALA - CYS - LEU - VAL - ASN - GLN - ASN - LEU -
LYS THR 
2 0 30 
AHG - LEU - K:3P - CYS - ARG - HI~':; - GLU - ASN - ASN - THR - A8N - LEU - PRO - - ILE - GLN - HIS -
LYS - ASP - I\SN - 8m -
40 
GLU - PHE - 8ER - LEU - THR - ARG - GLU - LYS - LYS - LYS - HIS - VAL - LEU - 88H - GLY - THR - LEU -
ARG 
50 60 
GLY - VAL - PRO - GLU - HIS - THR - TYR - ARG - SER - /\RG - VAIl - ASN - LEU - PHE - SER - ASP - ARG -
I L~~ 'rHR SER - ASN - GLN - rno -
10 80 
PHS - I LE - LYS - VAL - LEU - TH!1 - LEU - ALA - ASN - PHE - rrHR - Tlffi - LYS - ASP - GLU - GLY - ASP -
TYR -
90 100 
ITYR - MEr - CYS - GLU - LEU - ARG*- VAL - SER - GLY - GLN - ASN - PRO - THR - 8ER - 8ER - ASN - LY8 -
PHE GLN ALA ~1Er 
110 
rrHR - ILE - ASN - VAL - 1L8 - ARG - ASP - LYS - LEU - VAL - LYS - CYS 
SER SER TYR 
*For Mouse Thy 1.2 Position 89 is a GLN. 
f\) 
\.0 
Table 3. Carbohydrate Compositions. Carbohydrate Residues/per Molecule 
Mouse braina Mouse 1ympho- Rat brainc Rat thymocytec 
Thy-l.2 blastoidb Thy 1 
Thy-l.l 
Thy 11+ Thy 11-
Fuc 1.5 1.8 1.8 1.0 0·9 
Man 8.8 8.7 11·9 10.6 9.4 
Gal )~. 0 6.3 1.8 5.5 6.9 
Glu 0.0 0.0 0.6 1.3 1.1 
N-Ac-G1uNH2 4.4 8.6 6.3 7.0 8.3 
N-Ac-GalNH2 0.9 0.0 1.0 0.0 0.0 
NANA 0. 1+ 3.5 0.2 1.8 2.2 
Total 20.0 23.9 29.0 32.0 35·0 
aData from t~c Clain et al (41). 
b Data from Zwerner et a1 (42). 
CData from Barclay et al (34). 






















MOLECULAR COMPARISON OF MJUSE THY-1 AND rrs HUMAN HOrv10Lcx}UE 
(Molecular Immunology 19; 497-501, 1982) 
ABSTRAGr 
Physicochemical techniques were used to verify previous immune-
chemical studies showing homology of the human Thy-l (formerly p25) 
32 
antigen and the murine Tqy-l or antigen. Peptide maps and amino acid 
compositions showed close similarity between these two proteins; 
however, they were not identical. These data confirm that the p25 
antigen is the human homologue of mouse Tqy-l. 
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INTRODUCTION 
Few human lymphocyte antigens have been characterized biochemi-
cally, other than determinations of their molecular weights. 
Characterization of cell surface antigens and receptors has been 
difficult due to the low density of membrane antigens and the large 
nUMber of cells required for extraction of sufficient amounts of the 
desired molecules. Differentiation antigens from rats and mice, how-
ever, have been isolated in milligram quantities by extraction from 
tissues or organs (1,2). Using similar techniques, we previously 
located a T cell antigen with a molecular weight (M.W.) of 25,000 from 
a hlman lymphoblastoid T cell line (3). We have now isolated a 
sufficient quantity of this antigen to determine its peptide map and 
amino acid (a.a.) composition, and we have compared some biochemical 
properties of the human p25 and murine Thy-l antigens. Our results 
support the conclusion based on previous immunological comparisons that 
the p25 antigen is the human homologue of murine ~hy-l. 
MATERIALS AND METHODS 
Analytical sodiun dodecyl sulfate - polyacrylamide gel electro-
p!1oresis (SDS-PAGE) was performed according to the method of Laemmli et 
ale (4) using 5-20% gradient gels on a Hoefer electrophoresis 
apparatus. The gels were stained wi th Coonas s ie blue. r~olecular 
weight (M.W.) was estimated by comparison with a M.W. marker kit 
(Pharmacia, LMW). Molt-3 cells from large scale cell cultures (5) were 
gr8wn in suspension with 15% h eat-i~activated fetal c~lf serum, and 
isolation of the p25 antigen was perforned as described previously (3) 
with the following m::>difications. The packed cells were suspended in a 
pE 7.4 lysing medillM of 0.01 M ~ris-HC1, 0.015 ~ NaCl cont aining 0.01% 
egg white trypsin inhihi tor (Sigma.), 0.01 M phenylmethylsulfonylflou-
ride (CalBichem) and 0.0025% DNase (CalBiochem). The fraction eluted 
from a Sepharose 4B Lens culinaris coluTIn (Vector) was concentrated by 
air dialysis. An Ultrogel AcA-54 colunm was used, the desired 
fractions were concentrated by air dialysis, and preparative SDS-PAGE 
was performed. Approximately 0.5 ml of concentrated eluent -was lay ered 
on a gel 0.75 mm thick. The sides of the gel were cut off and stained 
with Coomassie blue to locate the 25,000 M.W. b~nd, Which was sliced 
out, fJomoge n i zed, and extracted wi th 0.5% deoXj-r-chola te (DOC), 10 ru·1 
Tris buffer. The acrylamide was re80ved from the buffer by high-s peed 
centrifugation (4000 xG) and the purified protein supernatant was 
concentrated by air dialys is to 1.19 rn..g/ml. We isolated 0.14 mg of the 
p25 ant igen per ml of packed cells. This isolated ant ige n was react ive 
with antisera raised against another preparation of p2 5 antigen (3). 
35 
This preparation of human p25 antigen (0.5 ml) and purified mouse 
Thy-1.2 (5) (0.45 mg at 1 mg/ml) were analyzed for a.a. composition by 
standard procedures using a Durrum D-500 automatic amino acid analyzer. 
Approximately 100 ug of protein was hydrolyzed in 6 N HC1, O.l~ phenol 
at 110°C llilder vacuum for 18 hr. For the hu.r18.n p25 antigen additional 
lyophilization and filtering were performed in order to remove discolo-
ration and particles. This discoloration was assumed to be due the 
presence of DOC. 
Sperm whale myoglobin (SWt1) was used as a control and subjected to 
the same procedures as the Thy-l and p25 ant igens. The corrected a. a. 
co~position was calculated as follows. For each a.a. the known number 
of a. a. was divided by the known number of res idues for SW~~, and the 
resulting figure was divided by the percent composition of the a.a. 
determined in SWM from our analysis. This factor was used to correct 
the content of each a.a. for the Thy-1 and p25 antigen by multiplying 
the observed percent composition to give a corrected percent 
composition as follows: 
(known no. of a.a. in SWM) / 
correct ion factor = known no. residues in S'",Tj-·1) 
(observed "!o composition in SWr.1) 
and 
corrected % composition = (observed ~ composition) x (correction 
factor) • 
A minimum of three runs were used to cal culate the compositions of the 
Thy-l and p25 ant igens. 
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Tryptic digests were performed on each sample (100-200 ug) in 0.05 
M NH4HC03 buffer, pH f.R, for 4 hr at 47°C vith an enzyme:substrate 
ratio of 1:50. The digest was applied to a O.l-rom micro-crystalline 
cellulose eEL 400-10 thin-layer plate (Brinkmann Instruments). First, 
ascending chromatography was performed using n-buty1 alcohol:glacial 
acetic acid:pyridine:water (15:6:12:10) solvent. Buffer for electro-
phoresis in the second dimension consisted of gla c ial acetic 
acid:pyridine:acetone:water (2:1:8:40) at pH 4.4. Constant current was 
applied at 300 V for 105 min. After drying, the plate was sprayed with 
a cadmiuhl-ninhydrin solut ion prepared bJ~ adding a 110 ni nhydrin solnt ion 
consisting of R~, acetone and 20% glacial ace~ic acid to a l~ solution 
of cadmium acetate at a ratio of 20 :1. 
An ethanol precipitation -was perforr1ed on t!1e remaining 150 ug of 
material. Three volumes of 100% ethanol were added to each sample, the 
sample was incubated at -20° C for 48 hr and centrifuged at 2,000 rpm 
for 15 min, the supernatant was decanted, and the precipitate was 
redissolved in watp r. During the ethanol precip itation, the hurlan 
glycoprotein tended to redissolve when brought to room temperature. 
Therefore, centrifugation was done at 4°c and the supernatant was 
iWQediately decanted. An additional composition and peptide map were 
obtained us ing this rna terial. 
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RESULTS 
By SDS-PAGE, human Thy-1 (p25) and mouse ~hy-1.2 migrated with the 
same Rf value. This SDS-PAGE analysis indicated a M.W. of 25,000 for 
both antigens. In Table 1, a.a. analyses are expressed as the mean 
number of each residue per 100 residues, excluding tryptophan. The 
mouse Thy-1 composition was similar to those reported previously (2,5) . 
The human p25 was similar to mouse and rat Thy-1 (1) except in the 
amounts of glycine and alanine present. The composition of SWM 
compared favorably with its published composition and was used to 
derive a correction factor, as described above. This rarely resulted 
in a correction difference of more than 10%. Hydrolysis of the 0.5% 
DOC-Tris eluting buffer showed no interference with a.a. resolution. 
In order to test whether the high content of glycine and alanine 
in the p25 antigen (Table 1) was real or an artifact, we performed an 
ethanol precipitation in order to remove any contamination due to 
eluting buffers. ~he glycine and alanine contents remained constant. 
The peptide r~ps obtained for p25 and Thy-1.2 were quite similar 
although not identical (Fig. 1). Several homologous peptides were 
found. ~he two spots that migrated farthest in the electrophoretic 
direction were arginine and lysine as determined from maps of other 
proteins containing arginines or lysines in juxtaposition, with no 
intervening trypsin-sensitive amino acids. 
DISCUSSION 
Previous Drumunological data have suggested identity or close 
similarity between the human p25 and JOOuse Thy-1 antigens (3). They 
have similar fv1.W., they are glycoproteins, and they share identical or 
cross-reactive antigenic determinants. Our comparison of the a.a. 
compositions and peptide maps of the two molecules (Table 1 and Fig. 1) 
indicates that they are closely related molecular species. Differences 
observed in the migration patterns of the p25 and murine Tby-1 antigen 
in the chromatography dimension could possibly be due to differences in 
carbohydrate moieties and not necessarily peptide differences. At 
present Ii ttle is known concerning the carbohydrate compos i tion of 
human Thy-1 antigen, whereas a large amount of data is available 
concerning the murine and rat Thy-l antigens (2,5). For example, the 
carbohydrate composition of murine Thy-l is about 2lf/o of its M.W. and 
for the rat this figure is 3Cf/o (1). Barclay et ale (1) found a M.W. of 
25,000 for rat Tby-l by SDS-PAGE, but by sedimentation equilibrium the 
~1.W. of rat brain Thy-1 was 17 ,500 and that of rat thymocyte Tby-1 
18,700. Thus they calculated the polypeptide portion to be approxi-
mately 12,500 daltons. We assume that the carbohydrate portion of the 
human antigen is similar to the murine and rat antigens since 
similarity was observed by peptide mapping. The M.W. of human Tby-l 
could be appreciably lower than 25,000. Quantitation of the 
carbohydrate moiety and its effect on the peptide mapping of these 
antigens is underway. 
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Subtle differences were observed not only in the migration 
patterns of the peptide maps but also in a.a. composition. These minor 
differences could be due to (a) our isolation procedure, (b) the fact 
that our antigen was derived from a ~mphoblastoid cell line, or 
(c) differences in cell function. Our technique of isolating large 
quantities of the p25 antigen by gel and lectin affinity chromatography 
could yield an antigen different from that retrieved by immunoprecipi-
tation with specific antisera. For exaMple, Barclay et ale (1) 
isolated a Tby-l antigen that bound to a lectin column and one that did 
not; both reacted with anti-Thy-l serum. They varied only slightly in 
amino acid composition, with greater differences in carbohydrate 
composition. Comparisons between lectin-purified p25 and immunopre-
cipitated p25 are now in progress in our laboratory. 
We assume that the antigen isolated from t~e lymphoblastoid cell 
line Molt-3 is identical to that found on normal lymphocytes in spite 
of an altered genome and expression of new antigens in these cells. 
Support for this ass~ption derives from our earlier immunoprecipita-
tion experiments (3). Also, in several cases identical molecules have 
been isolated from normal tissue and from malignant cell lines, 
including immunoglobulins, rosette receptors, and antigens such as 
beta2-microglobulin (6), HLA alloantigens (7) and, recently, mouse 
Thy-l.1 (8). 
The functional role of the murine and hunan Thy-l antigens is 
unclear at present. Conservation of structure of Thy-l antigen between 
species supports the theory of a necessary specific function. In the 
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mouse this antigen is found on t~ocytes, mature T cells, and brain 
cells (1). In the rat, brain and bone marrow cells are positive for 
T~-l whereas peripheral T lymphocytes are negative (1). In humans, 
the p25 antigen seems to be preferentially expressed on peripheral T 
lymphocytes and not on brain tissue (9). Ma ino et ale (10) have 
suggested that the murine Thy-l antigen is involved in T cell activa-
tion and proliferation, and McClain et ale (2) have suggested that the 
Thy-l antigens establish synaptic connections which are conserved in a 
variety of species and tissues. Perhaps the subtle differences between 
Thy-l antigens reflect differences in function. Correlations between 
the structure and function of these antigens, as well as information 
about their evolution, may be revealed by a.a. sequencing. Such 
studies are now in progress in our laboratory with murine and rat T~-l 
and with the human p25 antigen. 
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Table 1. Amino acid compositions of mammalian lymphocyte Thy-l antigens 
Amino Content (mol ~) in 
acid 
Human Mouse Mouse Mouse Rat 
Thy-l Thy-1.2 Thy-1.2a Thy-l.1b Thy-l .1 c 
ASX 11.5 (10.0)d 12.4 (10.8)d 13.3 12.0 12.6 
THR 6.7 (6.2) 7.9 (7 .3 ) 8.1 8.3 8.6 
SER 6.2 (6.0 ) 8.3 (8.0) 8.5 9.5 7.1 
GLX 12.2 (11.7) 10.8 (10.2) 11.3 10.6 9.1 
PRO 5.7 (5 .5 ) 4.1 (3 .9 ) 3.7 4.1 3.8 
GLY 10.3 (9.9) 5.7 (5 .4 ) 5.1 5 • 7 4.9 
ALA 10.0 (9.6 ) 5.0 (4 .8) 3.9 4.6 4.8 
VAL 7.1 (7 .9 ) 6.2 (6.8 ) 7.8 7.8 7.4 
MEr 0.9 (0.8 ) 2.0 (1.7) 1.3 1.5 0.9 
ILE 4.4 (5 .3) 3.8 (4 .6) 3.8 3.9 4.1 
LEU 9.2 (8 .6) 13.5 ( 12.4 ) 10.0 9.4 11.2 
TYR 2.3 (2.1) 3.1 (2.8 ) 3.4 3.5 2.0 
PHE 3.7 (3.0) 2.7 (2.2) 3.0 3.2 3.7 
HIS 1.4 (1.9 ) 2.8 (3.8 ) 3.6 3.7 3.8 
LYS 4.3 (4.9 ) 6.8 (7 • 7) 7.6 6.6 7.2 
Affi 2.7 (2.7) 4.8 (4.q) 6.3 5.8 7.5 
aFrom Acton et al. (5). - -
b From Zwerner et ale (8). 
cFrom Barclay ~t ale (1). 
dCorrected % composition (see Materials and Methods). 
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Fig. 1. SDS-PAGE analysis of human Tny-1 (p25) antigen (a) and murine 
Thy 1.2 (c). Low molecular weight markers (b,d) are shown for 
comparison. 
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ANTIGENIC DEI'ERMINANT (S) SHARED BY THE HUMAN THY 1 AND HUMAN IgG 
(Accepted by Immunobiology, January 1984) 
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A human T cell differentiation antigen (p25) previously described 
as being the mouse theta equivalent has been examined for shared 
antigenic determinants with tmmunoglobulin. A strong cross-reactivity 
of an antiserum prepared against p25 antigen was established with human 
IgG subclasses. This antiserum does not react with human IgM or 19A, 
nor with primate immunoglobulins. The shared determinants appear to be 
associated with the disulphide-bonded cysteines in the first and third 
constant domains of the 19G molecule and the 9-112 disulfide bond of 
Thy 1. 
INTRODUCT ION 
Thymus derived (T) lymphocytes are defined classically by their 
expression of receptors for sheep red blood cells (1). Other 
constituents of the T cell membrane include: HLA antigens (2), 
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Fc receptor (4)8 2-microglobulin (3), and numerous antigenic structures 
associated only with T cells (T cell specific cellular antigens) as 
defined by either heterologous or monoclonal antibodies (5). 
The products of immune responses, specific antibodies, and antigen 
specific T cell receptors are exquisite examples of recognition units 
for foreign and self antigenic structure. Whether the Thy-l antigen is 
the primordial immunoglobulin domain and possibly the T cell receptor 
as first proposed by Jensenius and Williams (6) is still enigmatic, 
although our data render support for this proposal. In this study, ~ 
find that an antiserum made to a T cell specific product (7), the hunan 
Thy-l molecule (8), can also react with a B cell specific product, 
human IgG. 
MATERIALS AND METHODS 
Antiserum. The antiserum was prepared as described previously (7). 
Briefly, a 25,000 M.W. fraction of cell membrane was isolated from a 
human T cell li ne and inj ect ed intramuscularly in complete Freund's 
adjuvant into a rabbi t. The second a.nd third inj ect ions we re gi yen 14 
and 28 days later in incomplete Freund's adjuvant. The antiserum 
obtained was heat inactivated and used without any adsorptions. 
Specificity of the antiserum for human T cells is as previously 
described (7,8). 
Cytotoxicity assay. The specificity of the antiserum for different 
lymphoblastoid cell lines was determined by using the 51Cr release 
cytotoxicity assay as described previously (9). 
Cell lines. The cell lines were graciously donated by Dr. Jean Michel 
Goust and Dr. Jan Minowada. 
ELISA assay. ~1icrotiter plates (Linbro) with 8x12 wells were used. 
The wells were coated with 100 ul of antigen (1-2 ug/ml). The plates 
were incubated at 37 ° C for 2 hr or at 4 ° C overnight • Plates were 
washed 3x with Dulbecco's phosphate-buffered saline (DPBS) and blocked 
with 5% bovine serum albumin (BSA) , incubated at 37°C for 30 min or 1% 
ESA overnight and washed 3x with DPBS containing 0.05% Tween-20. To 
each well, 100 ul of diluted antibody was added and the plate incubated 
at 31°C for 2 hr. The plates were then washed 3x with DPBS + Tween. 
100 ul of a 1:2000 dilution in 1% BSA of goat anti-rabbit antisera 
coupled with horse radish peroxidase was added to each well and 
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incubated for 1 hr at 31·C. The plate was then washed extensively (6x) 
with DPBS + Tween. Addition of 100 ul/we11 of 0.03% AHrS (2,2'-azino-
di-3-et~l-benzthiazolin-sulfonate, Boehringer, ~~nnheim, W. Germa~) 
in 0.1 M Na-citrate, pH 4.0, plus 0.003% H202 was made. The plate was 
covered and read between 15 and 30 min. in a Multiscan at 414 nm. 
Source of Antigens. Samples used included rat IgG (Miles Laboratory), 
chicken, cow, and sheep immunoglobulin (Pentex, Inc.), conalbumin (Dr. 
R.E. Feeney), alphal-antitrypsin (Dr. Philippe Arnaud), bet~-rri cro­
globulin (Ira Rosenshein), and human albunin fraction V. Pooled 
immunoglobulins from human, gorilla, and rhesus monkey as well as human 
myeloma IgG, IgA, and Wa:denstrom's IgM were isolated from sera by 
precipitation with sodi~~ sulphate, ion-exchange chromatography using a 
DE-52 column, and gel filtration chromatography using a Sephadex G-200 
or Sephacryl S-300 column as previously described (10). These Dnrnuno-
globulins were reactive with antiserum made to hunan immunoglobulins. 
Human transferrin was isolated by rivanol precipitation, starch-block 
electrophoresis, and gel filtration chromatography using a Sephadex 
G-100 column as previously described (11). 
Cyanogen bromide (CnBr) coupling to Sepharose 4B. Pooled normal human 
IgG, G-200 fraction, 150 mg, was coupled to 10 g CnBr activated 
Sepharose 4B according to the procedure of March et ale (12). 
Absorption experiments. The pooled hUMan IgG coupled Sepharose 4B ~s 
washed once with 1 M acetic acid, centrifuged, and washed 3x with PBS. 
Five hundred ul of antiserum was added, the sample was vortexed, and 
allowed to stand at room temperature for 2 hr. The sample ~s again 
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vortexed, centrifuged, and the absorbed antiserum was removed. This 
absorbed antiserum was used in the ELISA ass~r to test reactivity to 
human IgG and the p25 antigen. The IgG coupled Sepharose 4B column was 
then washed once with PBS and then 2x with 1 M acetic acid. The acetic 
acid wash was lyophilized and reconstituted to 500 ul with PBS and 
tested for its reactivity to hunan IgG. 
Molt 4 cells (lxlcP) were washed 2x with PBS. Five hundred ul of 
antiserum was added to the cells and incubated on a shaker for 2 hr at 
37°C. The cells were centrifuged and the absorbed antiserum removed 
and tested in the ELISA assay against human IgG and the p25 antigen. 
Care was taken to maintain an equivalent volume of antiserum (500 ul) 
for absorption with the Sepharose 4B coupled with human IgG column, the 
Molt 4 cells, and in the 1 M acetic acid wash. 
Reduction and Alkylation. IgM, IgA, and IgG protein samples were 
reduced and alkylated and the heavy (H) and light (L) chains separated 
as described previously (13). 
Isolation of IgG Fab and Fc fragments. Papain digestion of human IgG 
myeloma proteins and isolation and purification of Fab and Fc fragments 
was performed as described previously (14). 
Digestion of Fab fragments. Tryptic digests were perfonned on each 
sample in 0.05 ~1 NH4HC03 buffer, pH 7.8, for 4 hr at 37°C with an 
enzyme:substrate ratio of 1:50. Staph v-8 protease digestion was 
performed as desc ribed in Methods of Enzy1OO1ogy (15). Briefly, protein 
samples were dissolved in distilled H20 pH 4.0 at a 10 mg/ml solution 
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and allowed to equilibrate for 5 min at 37°C. The enzyme was dissolved 
in 1 M Na acetate pH 4.0 and added to the protein at a ratio of 1:100 
and incubated at 37°C for 20 min. The reaction was stopped by the 
addition of l~ trichloroacetic acid. 
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RESULTS 
Cytotoxicity assays were performed on a number of human and murine 
T cell lines in order to establish T cell specificity of the antiserum 
and relative amount of antigen per cell. Results are shown in Table 1. 
As can be seen from this Table, not all T cells are react ive wi th this 
antiserum according to the cytotoxicity assay, however, the antiserum 
possesses a high reactivi ty for Bal blc thymocytes. 
Determination of specificity of the antiserum was accomplished 
through use of the ELISA assay. React ivi ty to human IgG was determined 
to be as great as for the human purified p25 antigen (Figs. 1 and 2). 
The antiserum reacted with three different subclasses of IgG, i.e. 
IgGl' IgG2 , and IgG3 (Fig. 2). There was little or no reactivity to 
human albumin, conalbumin, alphal-antitrypsin, transferrin; sheep, 
chicken, or cow immunoglobulins; to rhesus, baboon, or gorilla 
immunoglobulin; rat myeloma, human IgM, human IgA, k or A light chains, 
reduced and alkylated human IgM heavy chain, IgA heavy chain, or IgG 
heavy chain. Mild react ivi ty (appro ximately 35"/0) was seen wi th rouse 
IgG and rat IgG, but none with mouse IgG2b and IgM (Fig. 3). Both the 
Fab and Fc fragments from papain digested human IgG reacted with the 
antiserum (Fig. 4). 
In order to determine Whether the antise~~ was recognizing a 
determinant shared by both the human Thy-l antigen and human IgG, 
absorption wi th human IgG coupled to Sepharose 4B or wi th Molt 4 T 
cells was performed. As can be seen in Fig. 5, the major i ty of the 
reactivity of the antiserum to IgG was removed by absorption wi th IgG 
while reactivity to IgG was also removed by absorption with Molt 4 
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cells (Fig. 5c). Partial reactivity to the 19G (Fig. 5d) was recovered 
from the 1 M acetic acid wash from the 19G coupled Sepharose 4B column. 
In Figure 6, reactivity to the p25 antigen was removed by absorption 
with Molt 4 cells and the 19G coupled to Sepharose 4B yet recovered 
from the 1 M acetic acid wash. Previous studies (7) using immunoab-
sorption and immunodepletion have shown complete removal of reactivity 
to the p25 antigen. Furthermore, as can be seen in Fig. 7, reactivity 
to 19G Fab fragments was removed (1:80) or greatly diminished by 




Thy 1 is a well-characterized membrane antigen wi th a wide tissue 
distribution (16). Although it is mainly present in high levels in 
neuronal cells and T cells, recent studies indicate that it is also 
detected in immature B cells (17). Recently, new ideas have appeared 
in the scientific Ii terature purporting a new function for the Thy 1 
antigen. Williams & Gagnon (18) have discovered structural and 
sequence homology between murine Th~y 1 and immunoglobulin, especially 
with the V (variable) region sequence. They suggest that Thy 1 may be 
like or is the primordial immunoglobulin domain. Jensenius & Williams 
(6) go so far as to suggest that Tqy 1 may replace current concepts of 
the T cell receptor. According to these investigators, the Thy 1 
molecule is the primordial immunoglobulin domain Which functions as a 
ligand which triggers cell-cell interactions by binding to a recognizer 
and that these two molecules, the ligand and the recognizer, could have 
evolved to produce the antibody and the histocompatibili ty systems. 
In earlier works, we have shown that the p25 antigen isolated from 
the human leukemic line, r-101t 3 is the human homologue to murine Thy 1 
(8). Similar procedures for isolation of both the human and mJrine 
Thy-l antigens were used; they both have identical molecular we~hts, 
both bind Lens culinaris lectin and are cross-reactive as shown by 
immunodepletion and absorption experiments (7). In addi tion, the p25 
antigen and muse Thy 1.2 have similar though not identical tryptic 
peptide maps and similar amino acid compositions (8). Therefore, we 
set out to determine whether the hup~n T~-l molecule shares homology 
with human immunoglobulin. 
As can be seen in Figures 2 and 5, the anti-p25 antiserun 
recognizes a common determinant on the p25 antigen as well as on human 
IgG. Since both the Fab and Fc fragments reacted with the antiserum 
(Fig. 4), we began to look for simila r sequences in the IgG heavy chain 
and murine ~hy 1 yet, could not be found in human IgM or IgA. The 
Sequence of Proteins of Immunological Interest Atlas (20) yielded two 
such positions. One was 123-126 and 238-2Lt2 of IgG, but there was not 
such a sequence in Murine Thy-l (18,19), while the other position was 
Ih4-1t~7 and 367-310. However, the amino acids in the latter positions 
are not exactly in the same sequence as murine Thy 1, thus prompting 
examination of the disulfide bonds (first and third constand domain) of 
hlunan IgG. As can be seen in Fig. 8, the sequence C L V-C V are 
conserved in most heavy chain domains. It is the identity of the 
surrounding amino acids which determine distinctive antigenicity. 
Reduced and alkylated IgG heavy chain is no longer reactive with the 
antiserum and on this basis one might predict the sequence of the hunan 
Thy 1 disulfide bond and the analogous Elurine disulfide bond 9-112, as 
the IOsition which closely resembles or is identical to the disulfide 
bonds of human IgG. Thus, if the antiserum was recognizing the 
disulfide bond in human IgG, trypsin should destroy this reactivity 
since a lysine is located at positions 147 and 370. Also, we predicted 
that digestion wi th Staph v-8 protease, which cleaves only at glutamyl 
residues in the system used (15), would not affect react ivi ty. These 
expected results were found with two different IgG Fab fragments as 
shown in Fig. 7. 
The antigen that was injected into the rabbit had been extracted 
from cell membrane and therefore had antigenic determinants exposed 
that normally would be buried in the cell membrane. It could be a 
determinant near the COOH terminal (one of many others), is being 
recognized by this antisera. 
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A natural question to be raised, is could antigenicity due to 
carbohydrate? The Thy-l molecule has been shown to be 20-30"/0 carbohy-
drate (9,16,21,22), and have t~Iee N-linked carbohydrate chains (18). 
However, IgG is only 1-3% carbohydrate, has only one carbohydrate 
moiety at position 237, and Kornfeld found a different sequence of 
sugars in seven IgG myeloma oligosaccharide chains (23). Other 
proteins tested have more carbohydrate than IgG: alpha1-antitrypsin is 
16%, and Ig~ is 7-12% with five carbohydrate chains (25). But what 
answers this question are the data which show 1) that both IgG Fab and 
Fc fragments react with the antiserum and that the Fab fragment lacks 
carbohydrate, 2) that trypsin digested Fab frag!11ent looses react ivi ty 
to the antisennn, and 3) that reduced and alkylated IgG no longer 
reacts with the antiserum. 
Dales and coworkers have recently discovered monoclonal antibodies 
with affinity for murine Thyl.l and Thyl.2 which also bind to actin and 
vimentin (26). Th~~ compared amino acid sequences of Thyl.2, smooth 
muscle actin and rabbit vimentin and showed suggested sequence homology 
as we have done with human IgG. 
In summary, we have demonstrated that an antiserum lmde to a human 
T cell specific product, reacts with a B cell specific product. We 
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have tried to pinpoint the shared antigenic determinants between human 
IgG and human Thy 1 through the use of antiserum reactivity, published 
Thy-l sequence data, and biochemical modification of the human IgG 
molecule. Our conclusions of shared antigenicity can only be further 
substantiated by determining the sequence of the human Thy 1 antigen 
which is now in progress in our laboratory. 
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5 1Cr Release Cytotoxicity Assay with Rabbit Anti-Human p25 













W • M. (woolly m:>nkey 
T cell) 






















40 80 160 500 1000 
Dilution of anti - p25 serum 
65 
Fig. 2. ELISA. assay sho\olir1~~ react i vi ty of four h-LLT1an Ig:} molecules 
with anti-p25 antisera. 
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fig. 5. ELISA ass~ reactivity to human IgG after (A) Reactivity of 
four human IgGs with unabsorbed anti-p25 antiserum plus reactivity to a 
control of normal rabbit serum. (B) Reactivity to the IgG's with 
anti-p25 antiserum absorbed with normal pooled human IgG. (C) 
Reactivity of human IgG to anti-p25 antisera after absorption with Molt 
4 cells (lxl06). (D) Reactivity of human IgG with acid vash of the IgG 
coupled Sepharose 4B column as seen in B. 
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Fig. 6. ELISA assay of anti-p25 reactivity to the p25 antigen after 
absorption with Molt 4, absorption with human IgG coupled to Sepharose 
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Fig. 7. Reactivi~ of trypsin digested, Staph v-B protease digested, 
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CHAPTER 4 
BI OCHEMICAL CHARACTERIZATION OF THE HUMAN THY 1 
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The human Thy 1 homologue was further characterized biochemically 
by sequence and carbohydrate studies. Two other forms of the human Thy 
1 molecule were detected and partially characterized. A 40,000 MW 
molecule is the dimer of the 25,000 MW Thy 1 molecule and its formation 
is increased by the presence of sodium dodecyl sulfate. The second 
form of 16,000 MW appears to be a cryptic or breakdown form of the 
25,000 Ww human Thy 1 molecule. 
INTRODUcr ION 
The Thy 1 or theta antigen was first detected on nurine brain and 
thymus as a cell surface alloantigen (1). Thy 1 can only be isolated 
in micelle formation using detergent. Rat brain Thy 1 carbohydrate 
composition has been determined (2) and the protein portion has been 
sequenced (3), as has been done for mouse brain Thy 1 (4,5). The 
rodent T~ 1 has been shown to consist of approximately 111 amino 
acids, it contains four cysteines and also contains three N-linked 
sugar chains. An unusual feature of the glycoprotein is the C-terminal 
peptide, as it does not contain any extended sequence of nydrophobic 
amino acids necessary for membrane anchorage (3). 
Human Thy 1 (also designated p25) has been isolated from a hUJl1an 
lymphoblastoid T cell line, nolt 3, and characterized by antigenic 
studies using cross-reactivity and immunoabsorption experiments with 
mouse Thy 1.2 (6). Human Thy 1 has the same rnlecular weight as its 
murine counterpart according to SDS-PAGE (sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis) (7). The human Thy 1 molecule was 
found to be similar though not identical to its murine ho~ologue ~J 
peptide mapping and amino acid composition. The s&~e types of 
comparisons have been made and similar conclusions drawn using T~y 1 
glycoprotein isolated from human brain and fibroblasts (8). 
In our present studies, we have detected two other forms of the 
human Thy 1 antigen. One fonn is approximately 40,000 daltons in MVl 
(molecular weight) a c cording to SDS-PAGE and is designated p40 and the 
other is 16,000 daltons MW, designated p16. Both forms are reactive 
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with antisera made to the human Thy 1 or p25 antigen. ~he p40 and p25 
seem to have al.most identical amino acid canposi+, Lons. The amino acid 
compos ition of the pl6 is also very similar. ~he carbohydrate 
composition of the p40 and p25 are similar while the p16 seems to have 
less carbohydrate. HPLC (high-pressure liquid chrorn.e.. tography) 
chroroatograms of tryptic digests of the p4 0 and p25 in their nnnaneric 
and in their aggregated formE are identical. The p16 tryptic peptioe 
chromatogram is di fferent but seems to contain a nUMber of ident ical 
+-.~ pep v1 1 es. Ther-efore, the p25 antigen appears to form as a di;ner t~1e 
p40 crea~, .. ed d"r~· n. g 1·so'lat,.1·on;· n t" l ted b ~ '-.A _ . 1 _ _ 1 ts IOrma 10n 1 S a CC e-Lera. y expo sure 
to SDS; and the ':'hy 1 may also exist in a breakjo-"TT1 form that is 
possibly pres e nt o n the cell surface. 
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MATERIALS AND METHODS 
Isolation: Molt 3 cells were grown according to procedures described 
previously (9) and isolation of the p25 antigen was performed as 
described previously (6) with the following modifications. After 
elut ion wi th 3% a1pha-:nethyl mannos ide of the Sepharose 4B Lens culi-
naris column (Vector), the bound fraction was applied to as-200 
Superfine column and the low molecular weight (LMW) fraction ~s 
applied to a preparative SDS-PAGE and extraction of protein ~s 
performed as described previously (7). The purified protein w.as 
concentrated by lyophilization and applied to a 12 cm x 0.5 cm Sephadex 
G-25 column in distilled water. This step was deemed necessary in 
order to remove contaminating glycine from the Tris-glycine SDS-PAGE 
and other contaminants w.hich interfered with carbohydrate analysis (See 
Figure 1). 
In one isolation procedure the preparative SDS-PAGE was fixed in a 
50% Trichloro-acetic acid (TCA) , 0.1% Coomassie Blue solution. The 
25,000 and 40,000 MW bands were excised and the protein extracted from 
the gel as described previously (7). 
The 25,000, 40,000 and 16,000 MW material -was also isolated from an 
immunosorbant column prepared essentially according to the method of 
Marsh et al. (10). The 1r-1 glacial acetic acid fraction was applied to 
a preparative SDS-PAGE and the protein extracted as previously 
dese ribed (7). 
n 
Analytical SDS-PAGE was performed according to the method of 
Laernmli (11), us ing a l~ or 12.5% gel on a Hoefer electrophoresis 
apparatus. The gels were stained with Coomassie Blue. If the bands 
were not visible by this stain, the gel was subsequently stained by the 
silver-nitrate method (12). 
Complete reduction of proteins was performed by addition of 10% 
B-mercaptoethanol and heating at 100°C for 5 min. in a heating block 
before application to SDS-PAGE. 
Production of Antisera: The antisera was raised as described 
previously (6). Briefly, rabbi ts were inj ected intramuscularly with 
the p25 antigen in complete Freund's adjuvant. Second and third 
injections followed 14 and 28 days later with incomplete Freund's 
adjuvant. 
Enzyme-linked Immunoadsorbant Assay, (ELISA): This ass~ was 
performed as described previously (13). 
Amino Acid Composition: r::'he amino acid (a.a.) compositions of purified 
p40, p25, and p16 antigens were analyzed qy standard procedures using a 
Durrum D-500 automatic amino acid analyzer. Approximately 50 ug of 
protein was 1vdrolyzed in 6N HCI, 0 .1,% phenol at 110°C under vacuum for 
18 hrs. Sperm whale myoglobin was used as a control and to correct 
a.a. composition calculations as described previously (7). 
Peptide Graphs of Tryptic Digests on HPLC: Tryptic digestions were 
performed as described previously (7). Separation of peptides was 
accomplished on a Waters High-Pressure Liquid Chromatograph, using an 
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ODS-Hypersil reverse phase column (Altex) essentially according to the 
parameters of Yang et ale (14). A linear gradient was run using a pH 
2.14 triflouro-acetic acid in distilled water as Buffer A and a 40% 
buffer A and 60% acetonitrile as Buffer B. The gradient ~s increased 
from 0-70% over 50 minutes at a flow rate of 1.5 ml/min while 
maintaining the colUMn temperature at either 45°C or 60°C. The eluate 
was read at 220 nm using a Kratos variable wavelength 
spectrophotometer. 
Carbohydrate Composition: Identification and quantitation of neutral 
and amino sugars was determined by the Rldito1 acetate method (15,16). 
Percent carbohydrate calculations were made according to the formula of 
Sloneker (17). Gas chromatography was performed on a Hewlett-Packard 
Model 5830A gas chromatograph equipped with dual flame ionization 
detectors. A 6 ft x 2 mm glass column packed with 3% SP-2340 was used. 
Injection temperature was 250°C and detector temperature was 350°C. 
Initial temperature was 190°C, held for 6 min then raised to a final 
temperature of 240°C at a rate of 1.7°/min. and held for 20 min. The 
carrier gas was nitrogen at 20 ml/min. Peak areas ~re measured and 
integrated by a Hewlett-Packard 18850A GC terminal. 
Approximately 100 ug of the samples V+O, p25, and p16 were qydro-
lyzed in 0.5 mls of 3N HCl at 80°C for 16 hrs. The samples were 
extracted 3X with 0.5 ml of n-hexane. Inositol acetate ~s added as an 
internal standard. The sample was incubated for 1 hr at room tempera-
ture after the addition of 0.5 ml of IN NH40H containing 2 mg NaBH4. 
The boric acid was then neutralized with acetic acid (app. 7 drops). 
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One ml of methanol:benzene (5:1) + 50 ul acetic acid ~s added to the 
sample and it was incubated at 80°C for 5 min. and then evaporated 
under nitrogen. This step was repeated 4x without benzene. The sample 
was completely dried and acetylated with 0.15 ml acetic anhydride at 
100°C, under nitrogen for 1 hr, after which 0.5 ml of chloroform was 
added to the sample and extracted 5X with 0.5 ml distilled water. The 
sample was dried and reconsituted in an appropriate volume of chloro-
form fo r inj ect ion. 
Cyanogen Bromide Cleavage: Approximately 20 ug of the p25 antigen was 
dissolved in 20 ul of 1~ formic acid, after which 20ul of a cyanogen 
bromide solution (25 mg Cnbr/l ml 70% formic acid) was added. The 
s~~ple was incubated at room temperature for six hours at which time 1 
ml of distilled water was added and the sample was lyophylized. 
Amino Acid Sequence Determination: N-terminal amino acid sequences 
were determined by Edman degradation with a Beckman Hodel 890 C 
automatic protein sequencer using a 0.1 M quadrol buffer. Identifica-
tion of amino acid phenylthiohydantoin derivatives was carried out with 
a Dupont high pressure liquid chromatograph. 
Immunoblot Technique: Immunoblotting was performed essentially 
according to the method of Tsang et ale (18) with rodifications in the 
staining procedure. Briefly, a DOC and a SDS solubilized membr&~e 
preparation of Molt 3 cells ~re electrophoresed on a 1.5 rom thick slab 
gel. The gel was then traDsblotted against a nitrocellulose transfer 
blot (Bio-Rad) overnight at 300 rna at 4°c in blotting medium, 0.025 r~ 
Tris, 0.193 t-1 glycine, in 2Cf/o methanol. The nitrocellulose was washed 
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3X with 1~ gelatin in PBS for 15 min. and then the anti-p25 antibody 
(1:100 dilution in 1~ gelatin) was appliei for 2 hrs under gentle 
shaking. ~he blot was then washed once in 1% gelatin/PBS and the 
secondary antibody [Goat anti-rahbit horse-radish peroxidase couplect 
(Cappel) 1:1000 in l~ gelatin] was applied for 2 hrs. The blot was 
then washed in PBS 2X for 15 min before applying the substrate, 0.05% 4 
chloro-l-napthol in PBS plus 0.1% H202 (3%) for 20-30 min. The blot 
was then washed with H20 and air dried. 
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RESULTS 
The major band seen after isolation of the LMW peak from the S-200 
Sephadex column was the p25 (see Fig. 2A). Concentration of the p40 and 
the p16 vary from preparation to preparation from undetectable to 
10-20% of total protein. Desalting on the small Sephadex G-25 was 
found necessary in order to remove glycine and other contaminants Which 
interfered with amino acid and carbohydrate compositions. 
As can be seen in Table 1, the a .a. composition of the p40 and p25 
are almost identical" as is the p16, though slightly different. These 
compositions are very similar to those reported for rrouse Thy 1 (4), 
rat Thy 1 (2) and human brain Thy 1 (8). By using the method to 
determine relatedness among proteins of Marchalonis and Weltman (19) 
vhich is based upon statistical analysis of differences in amino acid 
composition, we determined that the p25 and p40 are most closely 
related to the murine Thy 1 (see Table 2). The p25 a.a. composition 
was compared to that of 168 other proteins of which those proteins 
shown in Table 2 are representative. 
Figure 3 shows the relative migration distance of the p40 and the 
p25 on a 12.5% SDS-PAGE stained with Coomassie blue. 
The ELISA assay showed that all three antigens are reactive to 
antisera made against the p25. The p40 is more reactive than the p25 
which is in t urn more reactive than the p16 to antisera made to the p25 
antigen as shown in Figure 4. 
When the p25 and the p40 were run on a preparative SDS-PAGE and 
then fixed in the TCA-Coomassie blue fixing solution, then extracted, 
and rerun on a 1 Cf/o analyt ical SDS-PAGE, both Il'Olecules migrated 
identically. As can be seen in Figure 5, the now aggregated p25 and 
p40 migrated at an approximately 110,000 HW range. 
When the aggregated p25 and aggregated p40 were treated with a 
reducing agent, 8-mercaptoethanol, both reduced to the p40 form of 
identical migration on SDS-PAGE (Figure G). When the p40 molecule is 
reduced it is not converted to the p25 form (data not shown). The 
relative migration of the p16 molecule is shown in Figure 6d. Some 
microheterogeneity is seen as is characteristic of glycoproteins. 
When the P40, p25, and p16 were digested with trypsin and run on 
high pressure liquid chromatography at 60°C, the chromatograms appeared 
very similar for the p40 and the p25, yet, slightly different for the 
p16 (Figure 7). Twelve to fourteen peptides are seen as would be 
expected i~ a tryptic digest of the Thy 1 antigen. 
HPLC chromatograms of tryptic digests of the aggregated p40 and 
aggregated p25 also revealed the identical nature of these mlecules 
(Fig. 8). The tryptic peptide maps of the Aggregated molecules appear 
different from those of the non-aggregated molecules. This is because 
the aggregated maps were run ill1der a temperature of 45°C "While the 
t d t ·al at 60°C. non-aggrega e rna erl s were iLln The increased temperature 
induced the peptides to be eluted sooner. The approximate number of 
12-14 peaks remains the same for all proteins. 
Amino acid sequence determination of approximately 2 nmole of 
reduced and alkylated p25 revealed no PTH amino acid. It is likely the 
n-terminal amino acid of the nnlecule is blocked. Sequence 
determination of a cyanogen bromide peptide of p25 revealed a serine at 
the amino terminus. 
Carbohydrate analysis was performed using 100 ug of the p40, p25, 
and p16 antigens. The antigens were desalted on the G-25 Sephadex 
column before running on gas chromatography. Table 3 shows that the 
percentages of the mannose, galactose, glucose, and glucosamine are 
similar for the p40 and p25 antigens. However, the percentages for the 
p16 were quite different with no glucosa~ine detected. 
The presence of SDS seems to convert the p25 to the p40 molecule. 
In order to prove p25 conversion to the p40 form was induced by SDS, a 
membrane preparation of Molt 3 cells was dissolved in either 2.5% DOC 
or 2.0% SDS 10 mt-1 Tris-Rel. The immunoblot showed p25 and p4D in the 
DOC preparation and the absence of p25 vith greater amount of p40 in 
the SDS preparat iO!1 along -wi th act in and some high molecular weight 
material, perhaps the 110,000 MW aggregate (Figure 9). 
Molt 3 membrane preparations solubilized in DOC showed the presence 
of p25 by immw10blot, however the same preparation solublized in SDS 
did not show any detectable p25 (Figure 9). Both contained p40, actin, 
and assumed aggregated material. The anti-p25 serum has been shown to 
be slightly reactive to actin (manuscript submitted). In a membrane 
preparation, actin is present in a much greater amount than the p25 
molecule, therefore appearing as a much darker band on the immunoblot. 
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DISCUSSION 
The Thy 1 molecule is a glycoprotein found on rodent t~mocytes, T 
lymphocytes, neuronal cells, and fibroblasts. It has long been known 
as a marker for T cells in mice. The molecule has been sequenced in 
the mouse and rat brain and characterized according to the carbohydrate 
moieties (2-5). Homologues have been found in man (6,20), dog (21), 
and chicken (22). However, the antigen still remains a puzzle in 
several respects. For example, although predominantly found on 
neuronal cells, the expression of Thy 1 on lymphoid cells varies 
according to species. Thy 1 is abundant on mouse and rat thymocytes, 
and present on mouse T lymphocytes, yet absent from rat T lymphocytes 
(2). At present, there is a great deal of confusion and disagreement 
in the literature as to Where Thy 1 can be found in the human, and 
whether it is present on human tl~mocytes or T lymphocytes at all. 
According to McKenzie and Fabre (23) it is only present in discrete 
areas of t~mus, spleen, and lymph nodes, but according to Balch and 
Ades (24), it is expressed on thymus and peripheral T lymphocytes. 
This discrepancy is probably due to the specificity and method of 
production of antisera in each laboratory. These differences can only 
be res olved by isolation of the antigen from the tissues in question, 
followed by biochemical characterizat ion of the isolated antigen. 
We have shown in previous work (6) that the p25 antigen isolated 
from Molt 3, a human lymphoblastoid T cell line, is antigenically 
cross-reactive with mouse Tny 1, has a similar molecular weight, binds 
to Lens culinaris lectin, has a similar amino acid composition, and is 
similar by peptide mapping, though not identic al (,). Present st nd i e s 
i n die Ft t e t hat the p2 5 has 12 -1 4 t ry p tic pe P tid e s w71 i chi s s im i 1 R. r to 
the nUrrlbe r seen wi th trypti c diges ts of mur ine Thy 1: the p25 is 
a:pp~oximat~ly 20% cartohydra.te 'Wt-l i c h is similar t o rode:1t Thy 1 
(3,5,20); and se q uen c e st l~dies s :l.gge s t that the R.G1ino te~IJ inus is 
bloc ked bj' a pyro-gl"..ltHIna te as i s present in t h e r odent :I'hy l (3 ,5) . 
An-lino acid sequenci ng of a peptide created by treutr:'1ent of the p2 5 
mo::'ecule cyanogen broI1ide stows the arTJ ino terJ :,~inlls to be a serine wLicr} 
•. Q ~ 
po S =- t lO n _ t : This i s not se '2n in tr-; e r .s.t ?~r 1 
o ( (.-. ) u .) :) . 
r::uri :l~-: iso~_at ion o~~ tLe p2 :-1 antigen we no~iced bands of le ss er 
amount in the 40,000 lvfw ra.nge that usually cou2.d not 1)e completely 
removed from a p25 preparation, yet a 16, 0 00 }'11,.~ that c ould. 'r1h es e 
s im :i.lp~r d.J11i ; i:J FtC i:i c on: ~)O s ~ t iO:l e.r:J try pt ic di ge s t pept id e r!'.13. p s fr=>F. 
HP~S • 
tLe 
i niicR ting 
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exposure to SDS and is therefore a product of isolation. The dimeriza-
tion of the p25 to the p40 form could not be due to disulfide-bond 
interlinkage because it is not reduced by mercapthoethanol. Perhaps a 
hydrophobic moiety on the molecule is causing the dimerization. We do 
not know whether the p40 can be found on the cell membrane. 
Ours is not the first study to detect mole cules of di ffering 
molecular weight which are reactive to anti-~hy 1 antisera. Saj i and 
Tanigaki (25 ) isolated a Thy 1 like antigen fran a human T-cell 
leukemia cell line SKW-3 . 'I'hey detected a najor component of 30,000 MI.J 
and another of 110 ,000 ~1;': ·which reacted wi th their rabbit antise~um 
made against a Molt 3 glycoprotein . Our reduced and alkylated p25 
antigen also migrates at approximately 29,000 MW on SDS-PAGE. Perhaps 
t}lis 110,000 M"w molecule is related to the aggregated p25 and 
aggregated p40. Kuckel reported (26) a 230,000 ~w for rat Thy 1 in the 
absence of deox~cholate. 
Cau~er ~nj Co-l'n\re c +l"o ~ +O~s l"n 107 4\ (07 ) ~.J ~ i::i l . . --- v 0 Cl. v • ./ i \ L- I . isolated a 40,000 M"I'IT 
protein from Swiss n.lbino murine tJ-lymocytes. ~TIen this protein "WaS 
injected into .AKR r1ice, anti-theta alloantiserurrl was produced. This 
40,000 t,fvl protein W'8.S iS 81ated in the following 1Y1J.8..nner . A membra.ne 
fra.ction was stabilized in a Tris-Be l, 2't SDS buffer anj centrifu.gej. 
~he supernatant w. s appl ied to a Seph adex G-200 coluJ"'l.D and the 
fractions were dialyzed against distilled water. ~his differs fro~ the 
accepted PY'otocol of isolation 0: murin e Thy 1 which includes 
dissolving thememt) rane fraction in a 2.5~ DOC Tris-HCl buffer, 
centrifugation, and the superna~ant applied to a 2-ectin column (usually 
lens culinaris) and then gel filtration. We pr~ose that utilizing 
different solubilization techniques and a different detergent, SDS 
instead of DOC, causes the murine Thy 1 to dimerize to a 40 ,000 MW. 
Support for this proposal comes from immunoblots of Molt 3 membrane 
preparations using either SDS or DOC. In contrast to the DOC 
preparation, no p25 was detected in the SDS preparation. 
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Since Thy 1 is found on neuronal cells at synaptic junctions of the 
brain and since T lymphocytes are regulators, i.e., helpers and 
suppressors of the immune system, Thy 1 could be functioning in 
cell-cell cOMmunication. Seeds and his coworkers (28) have correlated 
the presence and absence of Thy 1 wi th the presence and absence of 
synapses in cuI tllres of brain aggrega tes. Willi ares and his group (29) 
have shown that anti-T~v 1 sera applied to brain can affect rat 
behavioral responses. These antibodies also inhibit virus-dependent 
proliferation of leukemia cells (30). ~ comparing sequence homologies 
of rat and mouse Thy 1 with immunoglobulin domains, HLA antigens, and 
b2microglobulin, Williams and Gagnon (5) have proposed that the Thy 1 
is the best candidate for a molecule which may approximate the 
primordial immunoglobulin domain. Thy 1 could function as a receptor 
for another molecule or one could argue that Thy 1 is a ligand to be 
recognized by receptors on other cells. 
Since the p16 antigen reacted to antisera and possessed similar 
amino acid composition to the p25 antigen, it is possible that the 
different migration on SDS-PAGE could be due to reduced amount of 
carbohydrate. The nolecular weight of rodent Thy 1 has been determined 
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to be 17-18,000 daltons by sedimentation equilibrium studies (26) and 
to be approximately 20-3a% carbohydrate (2,4). It is because of this 
increased carbohydrate content, wh ich affect s the mass/ charge ratio of 
the molecule, that the Thy 1 appears as 25,000 Ww on SDS-PAGE. If 
carbohydrate ~s reduced, the p25 molecule could theoretically migrate 
in the area of the p16 molecule. 
Carbohydrate analys is did not show the p25 and p4 a to be ident ical, 
yet this is wi thin the range of error for this type of analys is. ~he 
p16 antigen possessed conside rably fewer sugar residues compared to the 
p25. ~his p16 a~tigen is ass~~ed to be the pI6 antigen found on 
suppressor cells by Balch and coworkers (24,31). They prepared an 
anti-r:1onkey thyP.1ocyt e serum which recogn ized a 25 ,000 and a 16,000 MW 
ant igen. ~he 8.ntis~rum 'Was absorbed with Molt 4 , a T lymphoblastoid 
cell line which possesses the p25 but not the p16 antigen, thereby 
making the antisera specific for the p16 antigen. Using the pokeweed 
rni togen immunoglobulin-indtlction assay, they showed that a detergent 
soluble 16,000 M\o,T a!1tigen was expressed on h .. unan suppressor T lympho-
cytes and minimally on helper r:r lympho cytes . Agthoye~1 (32) found a 
25 ,000 ~Fd protei:1 associated wi th the T-3 antigen, a 19 ,000 MIt: protein, 
after tritiated ~abelling of human peripheral blood T lymphocytes and 
immunopr ecipi t 2~t ion. Bors t and cowo rke rs (33) found four di st i nct 
glycoproteins associated wi t"h the T-3 antigen irmnunoprec ipit.qtes from a 
hunan leukemia cell line HPB-ftLL. One of the complex had a molecular 
"..re ight of 25 -23 ,0 00 f,fw by SDS-PASE and after deglycosylation wi th 
Endoglycosidase? had an apparent molecular weight of 16,000. 
~herefore this JOOlecule has a If;-k dalton protein backbone and carries 
only N-linked, complex-type carbohydrate. 
The p16 could be a cryptic antigen, i.e., part of the p25's 
structure removed Qy some form of enzymatic degradation. Could it, the 
Thy 1, be processed in the cytoplasm and inserted in the membrane 
without the attachment of carbohydrate? Does the p16 antigen Playa 
role in suppressor T cell function or is it merely co-expressed and 
present as a breakdown product on older T lymphocytes? These questions 
remain to be answered, and mayor may not aid in determining the 
function of the Thy 1 molecule. 
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Table 1 
Amino Acid Compositions 
Approximate amino acid composition of 
p40 and p16 as compared to that of p25. 
Compositions are expressed in mol%; 
tryptophan and cysteine are not included. 
Values marked with a star are corrected 
values. Actual values were higher due 
to inadequate desalting procedure. 
Amino Acid p25 p40 p16 
ASX 12.0 11.6 11.3 
THR 6.3 6.7 6.4 
SER 6.2 5.5 6.6 
GLX 13.4 13.7 11.9 
PRO 5.9 6.6 3.8 
GLY 3.1 3.0* 3.8* 
ALA 5.7 5.0* 4.8* 
VAL 8.0 6.3 7.0 
MEr 1.4 1.3 1.5 
ILE 4.2 5.5 5.6 
LEU 9. 6 9.6 9.9 
TYR 2.6 3.0 2.5 
PRE 3.6 3.6 4.1 
HIS 1.8 2.0 2.6 
LY8 7.9 7.9 8.1 
ARG 4.8 4.5 5.6 
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Table 2 
Comparison of HUJl1Rn THY 1 to Various Proteins Utilizing SIlQ Calculations 
Prot ein S~(~ Protei!1 SllQ 
Mouse Thy 1.2 3h Kappa variable region 173 
Rat Thy 1.1 49 Lambda variable region 228 
Heavy variable region 148 
p40 antigen 7 Kappa constant region 151 
p16 antigen 13 Lambda constant region 181 
Hum.an heno£lobin 184 HUP1B.n CHl OU Ih2 
Human 82mic roglo hul in 5· 5 H"".lman CH2 142 
Human HLA B-27 135 HUIn.a.n CE3 210 
Human C-reactive + .: prove..i..n 78 HUr.1an CH4 134 
Nerve Growth Factor 198 
Actin 90 Human CAJ ~ 110 
Human Serum Albumin 72 Human garmra 114 
Cytochrome C 197 
Lysozyme 224 Human T chain 147 ( . ..' 
Ribonuclease 268 HUP1an complement component c4 65 
Calculations were performed according to the method of I\1archalonis and Weltman 
(19). This method determ ine the relatedness among proteins based u}X)n 
statistical analysis of differences in a.a. composition. Results have been 
shown to correlate closely wi~h comparisons based on the sequence of related 
prot eins. 
Where i and k identify t "he pa.rticular pr oteins which are being compared. Xj is 
the content of a give n amino acid of type j. 
Table 3 
% Carbohydrate Composition 
p25 p+o p16 
fucose 0 0 0 
rnannose 5~4% (8.3) 4.8% (7 .3) 4.3% (6.6 ) 
galactose 1.0 (1.8 ) 2.2 (4.0) .2 ( .3) 
glucose 1.R 3.3 1.2 
glucosamine .5 (1.4 ) .6 (1.8 ) 0 
galactosamine 0 0 0 
sialic acid N.D. N.D. N.D. 
Numbers in parenthesis are ca rbohydrate residues using 
published carbohydrate canposition for ell anti-tryps in 
as a correction factor (33). 
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Figure 1. Flow chart of isolation of Human Thy 1. 
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Figure 2A. Densitometer tracing of a silver-nitrate stained 12.5% 
SD8-PAGE of the LMW fraction from 8-200 8ephadex column. B. Same as 
above except this sample came from a recycled rnannoside elution of the 
lentil lectin column. Mainly the p16 band is seen. 
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Figure 3. A 12.5% SDS-PAGE of the (a) p40 molecule and (b) p25 





Figure 4. Results of Eliza ass~ showing the reactivity of the p40, 
















• P 16 
------------------------~r~-----------
20 40 laO 500 
antibody dilut ion 
102 
Figure 5. A 10% SDS-PAGE gel stained with Coomassie blue showing the 
aggregated p25 (a,b) and the aggregated p40 (c,d) as identical bands at 
approximately 110,000 MW position, as shown by the HMW standard (e) and 
LMW standard (r). 
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Figure 6. A 12.5% SDS-PAGE stained with silver-nitrate stain showing 
the (a) LMW standard (b) completely reduced aggregated p25 (c) 
completely reduced aggregated p40 and (d) p16 nolecule. 
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Figure 7. Tryptic peptide graphs from HPLC of the p40, p25, and p16 




Figure 8 . Tryptic peptide graphs from HPLC of the aggregated p25 (a) 
and the aggregated p40 (b) ITOlecules . The column temperature was IIBin-












Figure 9. An nitrocellulose ~unoblot showing (a) the DOC membrane 
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A 40,000 M.W. HUMAN THYMUS GLYCOPROTEIN RELATED 
TO HUMAN THY 1 HOMOLOGUE 
108 
SUMMARY 
A 40,000 M.W. glycoprotein was isolated from' human tQymus. This 
molecule binds lentil lectin, reacts with an antiserum made against the 
p25 antigen (the human Thy 1 homologue) and possesses almost identical 
amino acid composition as the p25 antigen and its 40,000 H.W. dimer. 
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INTRODUcrION 
The Theta or Thy 1 molecule ~s described originally as a murine 
brain and thymus antigen by Reif and Allen in 1964 (1). It has since 
served as a cell surface differentiation marker for tlvmocytes and 
mature T lymphocytes in mice (2). In rats, Tny 1 appears earlier in 
development than in mice with the antigen being present, in addition to 
brain and thymus, on bone marrow (2) and haemopoietic cells (3), but 
not on peripheral T cells (4-6). 
The Thy 1 antigen exists in similar quantities in human brain as 
compared to rodent brain (7); however, controversy exists concerning 
the existence of Thy 1 on human thymus (8-10). Dalchau and Fabre did 
not detect Thy 1 on human thymocytes in 1979 (11), but McKenzie and 
Fabre did detect Tny 1 in di screte areas of the thymus in 1981 (12), 
using an antiserum prepared against a human brain Thy 1 antigen. Balch 
and Ades (13) detected a 25,000 M.W. membrane antigen using an 
antiserum prepared against monkey thymocytes localized on normal T 
lymphocytes and human T lymphoblastoid cells. Ritter (14) found human 
Thy 1 present on 0.1-0.5% of bone marrow cells and 0.2-10.0% of 
thymocytes, with all Thy 1 positive T cells situated in the outer 
thymic cortex. 
After isolating a 25,000 M.W. glycoprotein from the M)LT-3 human T 
lymphoblastoid cell line and determining its homology with the murine 
Thy 1 molecule, we attempted to prove the presence or absence of this 
glycoprotein on human thymus. Also of importance was the determination 
of whether the 25,000 M.W. molecule isolated from the lymphoblastoid 
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cell line was similar if not identical to that found on normal tissue. 
After using the ~pical isolation procedure for murine and human Thy 1, 
little 25,000 M.W. glycoprotein was detected. However, a 40,000 M.W. 
glycoprotein with characteristics similar if not identical to the human 
Thy 1 was detected. In a previous study we found that the human T~ 1 
or p25 molecule seems to form a dimer of approximately 40,000 M.W. 
(Bonewald et al., submitted for publication). The 40,000 M.W. 
molecule isolated from human thymocytes is a glycoprotein, i.e., it 
binds to lentil lectin, reacts with antisera made against the p25 
antigen, and possesses an almost identical amino acid composition as 
the human Thy 1 and its 40,000 t~. W. dimer. 
III 
MATERIALS AND METHODS 
Normal t~us gland was obtained from patients aged 6 months to 12 
years who had portions of this gland removed as a necessary adjunct to 
cardiac surgery. The thymic fragment was immediately placed in saline, 
transferred to l640-RPMI (Gibco), the outer membrane removed, minced by 
scissors, and pressed through a nylon mesh bag into a single cell 
suspension. Red blood cells were removed by lysis in a 0.85% ammonium 
chloride solution and the cells washed in phosphate-buffered saline 
(PBS) and frozen until enough material was collected for isolation. 
Molt-3 cells were grown and harvested as described previously 
(15,16). Bovine muscle actin was purchased from Sigma. 
Isolation procedure 
Thymocytes were subjected to one of three isolation procedures: 
one is the standard procedure for the isolation of rodent Thy 1, one is 
an abbreviation of this procedure, and one is passage over an 
immunosorbent column. The standard isolation procedure is shown in 
Figure 1. 
In the second procedure, the material which bound to a lentil 
lectin column and that which did not bind was subjected to preparative 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as 
described previously (16). 
The third isolation procedure was identical to the previous 
procedure to the point of micelle formation of membrane glycoproteins 
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in the 2.5~ DOC supernatant. This material was applied directly to an 
immunosorbent column prepared using rabbit anti-p25 antisera (17). 
After application, the column was washed with PBS. The bound antigen 
was eluted using 1 M acetic acid, after Which this material was air 
concentrated. 
Preparation of immunosorbent column. 10 g of Sepharose 4B was 
activated by cyanogen bromide essentially as according to the method of 
March et ale (18) and reacted with 5 ml of rabbit anti-p25 antiserum. 
Enzyme-linked immunosorbent assay (ELISA). This ass~ was performed as 
described previously (19). 
Amino acid composition. The thymocyte antigen, the p25 antigen, and 
actin were analyzed for amino acid composition by standard procedures 
using a Durrum D-500 automatic amino acid analyzer. Approximately 
20-50 ug of protein was hydrolyzed in 6N HC1, 0.1% phenol at l100 e 
under vacuum for 18 hr. 
SDS-PAGE. Analytical SDS-PAGE was performed according to the method of 
Laemmli (20) using a 12.5~ gel on a Hoefer electrophoresis apparatus. 
The gels were stained by the silver ni trate TIEthod (21). 
Gel densitometry. Gel scanning was performed using a Joyce-Loeble 
Microdensitometer 3CS (England) with a 15.8 rom slit and a 446 filter 




When human t~ocytes were subjected to the identical isolation 
procedure as used for the isolation of rodent Thy 1 or human Thy 1, 
little or no 25,000 M.W. bands were seen in the LMW fraction of the 
8-200 superfine column. These results can be seen in densitometer 
tracings of 12.5% SDS-PAGE as shown in Figure 2. The LMW fraction from 
Molt-3 cells contains a great deal of the 25,000 M.W. or p25, with 
smaller amounts of bands at the 40,000 and 16,000 M.W. area. ~he 
thymocyte fraction showed no major band. 
For the next isolation procedure on human thymocytes, the lentil 
lectin eluted fraction was not applied to the S-200 column. Instead 
the material which bound to the lentil lectin and the fraction which 
did not bind to lentil lectin were air dialyzed and subjected to 
preparative SDS-PAGE. These different fractions were tested in the 
ELISA assay for reactivity to the anti-p25 antiserum. As shown in 
Figure 3, only one fraction (fraction #4, corresponding to 
approximately 40,000 ~1.W., bound to lentil lectin) reacted with the 
antiserum; none of the unbound fractions reacted. 
Next this bound fraction #4 was reduced and alkylated and reapplied 
to a preparative gel. A band of approximately 40,000 M.W. still 
reacted with the antiserum (data not shown). 
To decide whether this 40,000 H.W. band was actin, we performed 
amino acid composition of bovine muscle actin, ran gels comparing 
migration of the two proteins, and performed an ELISA assay to detect 
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any reactivity of the p25 antisera with actin. As shown in Figure 4, 
there is moderate reactivity of actin with the anti-p25 antisera. 
However, according to SDS-PAGE the actin migrates in the 45,000 to 
47,000 M.W. range, and a band corresponding to actin is not detected in 
the material that we isolated (Fig. 5). Our amino acid compositions of 
actin correspond very favorably with that reported by Tonarnura (22). 
As shown in Table 1, the amino acid compositions of the human p25 
isolated from Molt-3 cells and the 40,000 M.W. protein isolated from 
human tnymocytes differs clearly from that of actin. The key amino 
acid which demonstrates a distinct difference between the two proteins, 
actin and Thy 1, is methionine which is of considerably higher amount 
in actin. 
For the third i solation procedure, the human t~mocyte 2.5% DOC 
supernatant was applied to a rabbit anti-p25 immunosorbant column. 
When samples were taken ~ediately from the 1M acetic acid elution and 
electrophoresed on analytical gels, two bands corresponding to 
approximately 25,000 and 40,000 M.W. were seen and appeared identical 
to those seen with the same Molt-3 fraction (Fig. 6). However, after 
this wash had been pooled and concentrated by air dialysis at 4°c over 
several days and rerun on gels, the lower band had disappeared in the 
thymocyte concentrate but not in the Molt-3 concentrate (Fig. 7). To 
determine if the tqyIDocyte 40,000 M.W. band migrated in the same 
position as the Molt-3 40,000 M.W. band, the further concentrated 
samples were run simultaneously on a 12.5% SDS-PAGE. Figure 8 shows 
that the two bands migrate identically. 
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DISCUSSION 
The T~r 1 antigen is probably the most abundant cell-surface 
molecule found on mouse and rat thymocytes. Reif and Allen (1) found 
Thy 1 antigen is in greatest amount on murine brain and thymus, 
followed by lymph node and spleen, but none on bone marrow. Acton and 
coworkers (4) found the Thy 1 antigen on rat brain and t~mus, on 
spleen and bone marrow, but none on lymph node. Dalchau and Fabre (11) 
found canine Thy 1 on brain, kidney, t~mus, lymph node, spleen, and 
bone marrow, but found human Thy 1 only on brain and kidney. Although 
the Thy 1.1 alloantigenic determinant (which differs by a single amino 
acid substitution from Thy 1.2 in the mouse, arg for 1.1/gln for 1.2) 
is found in the rat, the 1.2 is not. Neither determinant is shared by 
canine or human Thy 1 (11). 
Arndt and Thiele (23) used anti-human brain antisera absorbed by 
standard methods and by demonstrating cross-reactivity between species 
showed little or no reactivity with human tqymus. McKenzie and Fabre 
(12) using an anti-human brain monoclonal antibody showed that hUMan 
thymus, spleen, and lymph node contain Thy 1 positive components in 
discrete patches. Saji and Tanigaki's (24) Thy I-like antigen was 
found in greatest quantity in brain, followed by testis, but also was 
found in all lymphoid tissues, including peripheral blood. 
Recently, Ritter et ale (14) found human Thy 1 present on 0.2%-10% 
of thymocytes in addition to bone marrow, 0.1-0.5%. Their data 
demonstrated that Thy 1 is present on early stages of both T and B 
lymphocytes. Their antisera included a rabbit anti-rat brain Thy 1 and 
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seven monoclonal antibodies to human brain Thy 1. Ades and co-workers 
(13) used an antiserum proepared against monkey thymocytes to identify a 
25,000 dalton surface protein on normal human T lymphocytes. There-
fore~ confusion continues to exist concerning the presence or absence 
of Thy I on human thymocytes and T lymphocytes. 
For our detection method~ we have used standard isolation 
procedures for the theta antigen (25~26) and an tmmunosorbant column 
made with rabbit anti-p25. The p25 is an antigen purified from a 
human lymphoblastoid cell line~ Molt-3. This replaces the serological 
oirnmunosorption experiments used by previous investigat ors. 
In a previous paper (Bonewald et al.~ submitted for publication)~ 
we have shown that the human Thy 1 or p25 antigen can be converted to a 
40 ,000 M. W. protein, especially after exposure to SDS. Sauser et ale 
(27) using SDS for detergent and a solubilization agent of a cell 
membrane f'raction from mouse thymocytes, isolated a 40,000 M.W. Thy 1 
antigen. This is in contrast to the 25,000 M.W. Thy 1 isolated using 
DOC as the solubilizing agent (7~25,26,28). 
Only two pieces of our data show that the Thy 1 may exist in a 
25,000 H.W. form on human thymocytes. One is the 25,000 M.W. peak 
seen on gels immediately after the 1 M acetic acid elution of the 
anti-p25 column. The second is a faint band in the area of 25,000 
daltons on the LMW fraction of the S-200 column. Therefore, if the 
25,000 M.W. protein is present on the cell surface it is rapidly 
converted to the 40,000 M.W. form during isolation. 
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In previous work, we established that SDS could convert the p25 or 
Thy 1 to a 40,000 form, but from the present data it seems that acetic 
acid may also cause conversion. The thymocyte roolecule may be particu-
larly susceptible to this transformation. Since the amino acid compo-
sitions appear similar, perhaps differences lie in the carbohydrate 
content which could influence susceptibility to conversion. Hoessli et 
ale (29) determined that T-lymphocyte differentiation in the mouse is 
accompanied by an increase in Thy 1 sialic acid by neuraminidase 
determinations. Carlsson and Stigbrand (30) demonstrated carbohydrate 
complexi ty in the rrouse thymocyt e Thy I by lect in affini ty and 
i soelect ric fo cus ing. 
The most pressing question after discovering reactivity of our 
·antiserum with the 40,000 M.W. fraction was ~- could we be detecting 
actin? Actin is a highly conserved protein found in abundance in all 
eukaryotic cells. The amino acid sequence and composition is highly 
conserved and it mainly plays a role in muscle contraction. Although 
actin could be a minor contaminant, our amino acid compositions prove 
that the t~mocyte molecule being detected is not actin. Also, actin 
migrates considerably slower on SDS-PAGE (45-47,000 M.W. range) than 
the 40,000 r~.w. protein. 
Cross-reactivity of our antiserum with actin may be due to 
contamination of the original p25 preparation used for inj ect ion in 
rabbits. However, the antiserum may be detecting cross-reactivity 
between the Thy 1 and actin. Dales et ale (31) discovered IOC>noclonal 
antibodies with affintiy for Thy 1.1 and Thy 1.2 which also bind to 
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actin and vimentin. Computer analysis of amino acid sequences of 
murine Thy 1.2, rabbit and chicken skeletal or smooth muscle actin and 
rabbit vimentin showed suggestive sequence homology. However, exposure 
of living Thy 1.2 or 1.1 thymocytes to actin antibody did not produce 
any detectable surface binding which demonstrates the absence of actin 
from the thymocyte surface. 
In conclusion, the hUMan thymocyte Thy 1 must be rrore similar to 
the 40,000 M.W. dimer than the 25,000 M.W. antigen isolated from 
Molt-3, a human T lymphoblastoid cell line. 
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Table 1 
Amino acid compositions are expressed in rnol%; 
tryptophan and cysteine are not included. Data from 
Tonamura's laboratory was converted from number of 
amino acid residues for a rrolecular weight of 




























































































Fig. 1. Flow sheet for isolation of human Thy 1 from Molt-3 cells. 
The same procedures . were used in human thymocyte isO'lation. 
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Fig. 2. A densitometric tracing of the LMW fractions collected from 
8-200 superfine column of a Molt-3 preparation and a human thymus 
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Fig. 3. An ELISA assay showing reactivity of rabbit anti-p25 with 
materials bound to lentil lectin and those unbound to lentil lectin 
fractions isolated by preparative SDS-PAGE from thymocytes. The x-axis 
denotes dilution of antisera and the y-axis is absorbance at 414 nm. 
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Fig. 4. An Elisa assay showing reactivity of anti-p25 sera with human 
Thy 1 isolated form Molt-3 and bovine muscle actin. 
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Fig . 5 . A gel densitometric tracing of a 10% SDS-PAGE stained by the 
silver nitrate method . The top of the gel proceeds from the left to 
the' dye front on the right . Relative positions of actin and 
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Fig. 6. Gel densitometric tracings of two 12.5% SDS-PAGE stained qy 
the silver nitrate method. The sample is taken from the 1 M acetic 
















Fig. 7. Same as Figure 6 except the samples were taken from air 
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Fig. H. Same as Figure 7 except the samples were further concentrated 
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THE THY 1 K)LECULE APPEARS TO BE A LIPCX;LYCOPROTEIN 
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INl'RODUCTION 
Two other forms of the human Thy 1 (p25) molecule have been noted 
and biochemically characterized (1). One form is approximately 40,000 
MW (p40) according to SDS-PAGE, the dimerized form of p25 and the other 
is 16,000 M\-;r (p16), possibly a breakdown product of the p25. Both 
forms are reactive with antisera made to the human Thy 1 or p25 
antigen. The p40 and p25 seem to have almost identical amino acid 
compositions. The amino acid composition of the p16 is also very 
similar. The carbohydrate composition of the p40 and p25 are very 
similar ~ile the p16 seems to have little carbohydrate. The most 
unusual characteristic of these molecules is the possession of lipid 
components, two fatty acids, again in almost identical proportions in 
the p4 0 and p25 t yet di fferent although present in the p16. These data 
seem to suggest that the human Thy 1 is a lipoglycoprotein. 
MATERIALS AND METHODS 
The p25, p40 and p16 molecules were isolated and vurif1ed as 
described previously using preparative SDS-PAGE and a miniature 
desalting G-25 column (1). 
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Fatty acid analysis: The n-hexane extracted material from the 
hydrolyzed sample from alditol acetate preparations (2) or from Tri-
methyl silylated (T~3) preparations (3) were evaporated under nitrogen. 
Approximately 25 ul of Tri-Sil (Pierce) was arlded to the alditol 
acetate samples. Normal fatty acids were determined qualitatively and 
quantitatively by gas-liquid chromatograp~ of the fatty acid met~l 
esters obt ained frOT'l the ~thanolyza te. 
The sample was reconstituted in chloroform and injected onto a 1~ 
SP-2330, 6 ft x 2 rom glass gas chromatography column. Initial 
temperature v.as 160·c, held for 10 min and increased to 190°C at a rate 
of 3· /min and held at the final temperature for 20 min. Inj ection 
temperature was 250°C. The carrier gas was nitrogen at a flow rate of 
20 ml/min. Using a flame-ionization gas chromatograph, 1 ug of each 
fatty acid could be arlequately detected at 32 x 10 -1- AFS sensitivity. 
The area of the c16 peak was di vided by the area of the CI8 peak to 
determine ratios for each molecule tested. 
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RESULTS 
Whether the samples were desalted or not desalted, the same 
results were obtained on the fatty acid analysis. Table 1 gives the 
ratio of the first peak to the second peak. The tvo fatty acids seen 
to be be c16 0 and CI8 I according to the elution times of the fatty 
acid standard (Pierce). For three different extractions the ratio for 
the p25 and p40 were very similar (.68). The ratio for the p16 was 
always less (.51). Other bands that were eluted fran the gel, such as a 
12,000 MW,a 20,000 MW and a 67,000 ~w bands did not have aQY fatty 
acids according to this ass~. These two peaks were not present when 
the aggregated p25 and p40 were analyzed. In one ass~ more than t~o 
peaks we re seen. 
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DISCUSSION 
There is an unusual carboxyl terminal found on the Thy 1 molecule. 
When sequencing rat brain Tny 1, Campbell (4) could obtain the 
C-ter.minal peptide either in h1ghlyaggregated form or could purifY it 
only in Brig 96 detergent. It appeared to have hydrophobic properties 
yet contained fev nydrophobic amino acids. He found unidentified 
ninhydrin-positive material and glucosamine and galactosamine. He 
suggested that the C-terminal may be linked to lipid. If so, this 
~uld make the Thy 1 and unusual molecule indeed. Barclay and 
coworkers (5) mentioned minor unidentified peaks in carbohydrate 
analysis which they thought to be stearic acid. Other investigators 
such a.s Sauser (6) assumed a IlX)lecular canplex between a protein roiety 
'. and a glyco1.tpid existed for the Thy 1. If lipid is present, is it 
covalently or ~drogen bonded to the molecule? 
We performed a fatty acid analysis on the n-hexane extraction of 
hydrolyzed ~ 0, p25, or p16. Surprisingly,. we found two fairly common 
fatty acids. The ratio of the c16 to the c18 fatty acid ~s almost 
always identical in the p40 and p25 molecules, however the p16 ratio 
vas always less. Again this demonstrates that tbe p40 and p25 are t he 
same molecule and the p16 is differing in the a spect of lipid content 
in addition to possessing less carbohydrate (1). We as sume t hat these 
two fatty acids are part of a lipid moiety bound to the molecule. The 
lipid moiety must be covalently bound since the antigens were extracted 
from a Tris-glycine SDS-polyacrylamide gel. Nonnally free lipid 
components would migrate to the dye front. This would also explain our 
loss of the p25 antigen when dialyzed against buffer containing no 
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detergent. 'Sauser (6) also found that prolonged dialysis against cold 
distilled vater or repeated freezing and thawing of the protein reduced 
antigenic activity. ' Lipid has a high affinit,y for dialysis membrane. 
There are very few examples in the literature of lipid covalently 
attached to protein. One example is that of Rantke and Braun (7) who 
characterized a murine-lipoprotein, in which a thioether bond linked a 
cysteine side chain to a diglyceride and a third fatty acid is attached 
to the N-terminal amino acid group of the cysteine. Fatty acids can 
also be covalently attached to carbohydrate such as the sugar glucose 
in the case of acyl-glucosylcerarnides (8). We tend to favor the 
proposal that lipid is attached to the p25 molecule via a carboxyl 
terminal cysteine similar or identical to cysteine #111 or #112 
identified from sequence data of mouse and rat Tqy 1 (~,9) •. 
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Table 1. FATTY ACID ANALYSIS 
ratio of C16 peak 
'" composition of p25 
p25 = .68 (3) 
p40 = .68 (3) 
p16 = .51 (3) 
2.7~ C160 
3.1% C18 1 
6.8% total 




Figure 1. A gas chromatograph tracing of a fatty acid analysis of the 
p25 molecule showing the presence of two peaks corresponding to C16 and 
e18 1 • 
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The. Thy 1 or theta antigen was one of the first differentiation 
antigens on lytnphocytes to be dese rlbed. However useful it has been in 
the mouse model, to date ' such does not hold true for the rat, dog, or 
human since the antigen does not show similari~ in tissue distribution 
across species except for expression in brain. When this study began 
few human ~phocyte antigens had been biochemically characterized 
beyond molecular weight detennination . This was due to two reasons: 
one, the unavailability of human tissue and, two, the relatively low 
density of memb rane antigens on cell surface nB.king necessary large 
amounts of material or tissue in order to isolate purified antigens in 
sufficient a~ount for biochemical studies. In our case, this problem 
was overcome by utilizing large-scale cell cultures of a human T 
lymphoblastoid cell line, Molt-3 (1) . The same isolation procedure 
using DOC as solubilizing detergent as used for lIX)st murine Thy 1 
isolation was used for human material. A T cell antigen of molecular 
-we ight 25,000 was isolated from the Molt 3 cell line (2). 
The p25 antigen when canpared to the murine Thy 1 had the same 
molecular weight, bound to lentil lectin (a characteristic of 
glycoproteins 'Which p::>s sess mannose), and by using immunodepletion and 
immunoabsorption experiments it was revealed murine Thy 1.2 and p25 
were cross-reactive. This immunological data was borne out by 
biochemical data showing similarity but not identity utilizing amino 
acid composition, tryptic peptide maps and carbohydrate analysis. In 
addition, our data demonstrated antigenic det erminants shared by mur i ne 
IgG and hll.lnan Thy 1 as well as human thymocyte. We also demons trate a 
diineric form and a non-carbohydrate bearing form of the molecul e. It 
is our contention that the p25 antigen is the mouse T~ 1 or theta 
equi valent. 
Antiserum made to the isolated and purified T cell product, the 
p25 molecule, reacted strbngly with a purified B cell product, human 
IgG. Cross-reactivity with human IgM, 19A, primate Ig, murine Ig, and 
a battery of other antigens is low or non-existent. Both the Fab and 
Fc portion of the human IgG molecule reacted vith the antiserum, 
wherease reduced and alkylated, or trypsin-digested IgG did not. This 
suggests a defined, tertiary structure of the molecule which includes 
the disulfide bonds as necessary 'for reactivity. Carbohydrate noieties 
on the IgG molecule were definitely ruled out while the disulfide bonds 
of the first and third domains of human IgG are implicated as the 
reactive site. Perhaps ., isolation and purification of the p25 molecule 
us ing DOC exposed new antigenic sites not exposed on the cell surface, 
thus the cross-reactivity to IgG. Molt 3 does not possess nor 
synthesize IgG. 
These observations are interesting in light of theory recently 
proposed by Williams and Gagnon (3) suggesting that the Thy 1 molecule 
may be or is like the primordial immunoglobulin domain or the theory 
proposed by Jensensius and Williams (4) that the Thy 1 molecule is the 
T cell receptor. Our da ta see"ns to support the previous proposal of 
homology between Thy 1 and Ig, howeve r, the 1a tter pr oposal rena ins as 
speculation. 
Recently, utilizing monoclonal antibodies there have been examples 
of shared antigenici ty of Thy 1 and act in (5) and '!'hy 1 and a canponent 
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of 1ntennidate filaments (6). These investigators also suggest 
homology based on a computer search and campa~i8on of sequence data. 
Extrapolating from shared antigenic determinants to molecular homology, 
and especially extrapolating further into shared similar function is a 
tenuous area of speculation. 
During isolation of the p25 antigen, two other forms of the 
antigen were noted and characterized. One being the dimerized p25, is 
designated the p40 molecule. At first appearance, this band on SDS-
PAGE was confusing until it was noted that preparative SDS-PAGE greatly 
increased its presence. Immunoblot experiments of DOC membrane extrac-
tions and SDS membrane extraction showed that SDS converts the p25 form 
into the p40 form. This supp::>rts Sauser et ale (7) whose data in 1974 
demonstrated that the muse Thy 1 is a: 40,000 dalton IlDlecule. Sauser 
is the only investigator in the literature who used 2% SDS instead of 
2.5% DOC to isolate the molecule. (Brig 96 and Nonidet have also been 
used.) Other investigators (8) have assuned that a contaminating 
molecule of 40,000 daltons was present in Sauser's thymocyte prepara-
t ion and assume a "true" !ll)lecular weight of the Thy 1 molecule to be 
25,000. Our data are the first to support and vindicate Sauser's work. 
The otber fom isolated was the p16 molecule which is p::>ssibly a 
breakdown product of the p25. Ades and coworkers (14) found a 16,000 
MW molecule associated with suppressor cells. The ~101t 3 cell line 
possesses both the p25 and the p16, Whereas the Molt 4 possesses the 
p25, yet lacks the p16 antigen. Although biochemical studies bore out 
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the identity of the ~ ° and p25 molecule t the same \laS not true for the 
p16 . Amino acid · compositions were very similar which suggests the 
protein structure or backbone 'W.s intact. However t the p16 appeared to 
possess considerably less carbohydrate than the p25 molecule, yet 
retained lipid material according to fatty acid analysis. (Such a 
molecule has not been reported in the murine system). The pl6 could be 
a cryptic antigen, i.e., part of the p25 structure removed by enzymatic 
degradation. Perhaps the pI6 could be the p25 processed in the cyto-
plasm without the attachment of carbohydrate and then inserted in the 
membrane. The pI6 molecule may play a role in suppressor T cell 
function or be a differentiation antigen co-expressed on these cells. 
Determination of molecular weight is dependent on the method of 
iso lation used and t his statement is especially true when dealing vi th 
surface membrane antigens. Membrane roolelcules are usually present in 
relatively small amounts and detergent is necessary for their isola-
tion. Detergent can be difficult to work with and can interfere vi t h 
biochemical methods such as amino acid sequencing. The histocompati-
bility leukocyte antigens (liLA), though membrane antigens, were 
sequenced fairly . easily because it was determined that a papain single 
enzymatic cleavage site close to the cell surface would separate t he 
majority of the molecule from its qydrophobic tail piece (9,10). 
The standard isolation procedure used for isolation of Thy 1 
utilizes DOC and yields a product of 25,000 MW by SDS-PAGE. However, 
by sedimentation studi es the M"w is. 17 -18 9 000 (11). We have shown t hat. 
by using SDS in place of DOC the rrolecule' s apparent molecular "'Weight 
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is 40~000. Atwell and Marchalonis (12) isolated a 60,000 MW theta 
antigen. This could be due to further aggregation of the molecule 
since they used an immunoabsorbant column in their isolation proceudre 
and eluted the IIB.terial wi th 1M acetic acid. '!'his is in contrast to 
Cotmore (13J who also used an imrnunoabsorbant column, but eluted vi th 
diethylamine and retrieved a molecule of 25,000 MW. In our studies, 
when the p25 and p40 were fixed in a TCA-Coomassie blue solution, th~ 
both aggregated to approximately 110,000 MW. Kuchel (11) found mouse 
Thy 1 aggregates in the absence of detergent to a IJX)lecul ar weight of 
230,000-300,000. Therefore, cons ideration of isolation procedures is 
important in reporting IIDlecular weight. 
The p40 or dimerized form of the p25 antigen is a curious molecule 
because it does not revert h8.ck to the p25 form when treated with a 
reducing agent. This suggests that dimerization is not due to 
disulphide bond interchange. Perhaps another form of interchange has 
occurred and we specul ate that the :qydropbobic portion of the IIDlecule 
plays a role i n this. If lipid or fatty acids are present, any 
unsaturated bonds may interchange between fatty acids. 
H H H H H H H H H H 
2 H-C(n)-C-C=C-C(n)-R = R-C(n)-C-C-C(n)-C-H 
H H H H H H H 
H H H H 
H-C-C(n)-C-C-C(n)-R 
H H H H H 
Of course at his time, this speculation remains to be proved. 
It was of .importance to determine 'Whether the p25 molecule coul d 
als o be found on nonnal tissue and whether identity existed wi th the 
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p25 material isolated froo the lymphoblastoid cell line. After using 
similar' amounts of huma..n thyzoocyte as used in a Molt 3 isolation, 
Ii tt1e if any 25 ,000 HW band was seen on SDS-PAGE of the LMW peak from 
gel filtration. Yet · When preparative gels were run on tnymocyte 
material which was concentrated from the bound and unbound eluate of a 
lentil lectin column, a fraction corresponding to bound, 40,000 MW, 
reacted with anti-p25 serum. None was noted in the 25,000 MW range. 
When a DOC membrane preparation of human thymus was applied to an 
anti-p25 imnrunosorbant c o lumn, washed and eluted with 1 M Acetic Acid, 
tva peaks were observed on SDS-PAGE. When concentrated by air dialysis 
only a single band was observed on gels. Some conversion had occurred 
in the Holt 3 preparation but not to the extent of complete conversion 
as seen with the thymus material. The thymus material and p25 antigen 
had very simi l ar ami no acid compositions. 
The antigen may exist in the 25,000 MW form on the human t~mocyte 
yet because it is p~es ent in quantities considerably less than that 
found on f.101t 3 «10'% ) , perbaps it is IIDre readily converted into a 
dimerized form. Ritter (15) also found Thy 1 to be present in small 
amounts in the human tqy-mus (0.2-10%). Therefore, the Thy 1 antigen 
cannot be used as a T cell di ffer'entiation marker in the human, as is 
also true in the dog. The mouse appears to be the only animal in which 
the Thy 1 antigen appears in abundance on peripheral T lymphocytes. 
Only in rodents does the Thy 1 appear in abundance on thymus, in 
c ont.rast to the dog a nd human. 
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Our studies suggest the presence of lipid in the p25 molecule. 
This is shown ~ 1) the necessity of detergent for its isolation, 
2) the removal of detergent by dialysis results in loss of the p25 
molecule and 3) n-hexane extractable material 1n ~drolyzates of the 
p25 molecule. The material which lends hydrophobicity to the molecule 
is probably covalently attached. 
In summary, evidence which supports the homology of murine Thy 1 
and the human Thy 1 or p25 antigen is: 
1. both are 25,000 MW by SDS-PAGE. 
2. both are glycoproteins ~ ich contain high rrnnnose content, 
i. e. ,they bind to Lens culinaris lentil lectin. 
3. Cross-reactivity has been shovn by ~oabsorption and 
immunodepletion experiments. 
4. Amino acid compositions are similar, yet not identical. 
5. Tryptic peptide maps are similar, yet not identical. 
6. A 40,000 MW form can be seen with SDS-conversion. 
7. HPLC tryptic peptide maps of the p25 contain 12-14 peptides as 
_vould be expected for the number of arginines and lysines in 
the amino acid compositions. 
8. The p25 molecule possesses approximately 2Cf/o carbohydrate 
compared to the murine content of 20-30%. 
9. The N-terrninal amino acid of the p25 appears to be blocked as 
1s . true of the rodent Thy 1. Serine appears to be the amino 
acid following methionine as is true of IIDuse but not rat Thy 
1. 
Additional observations accomplished include; antigenic 
determinants shared by human IgG and human Thy 1 antigen, the presence 
of a molecule related to the p25 of 16,000 ~fW, and a human thymus 
40,000 MW glycoprotein is related to the human Thy 1. 
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*Early T cell 
**Pre B cell 
T Lymphoid Lineage 
Binding · 100% Neg. 
Counts Lysis Control 
Dilution (l:X) 
% Lysis 
x=4 8 16 32 64 
2,000 70 15 23 
5,000 71 17 27 
7,000 76 20 
2,000 84 33 48 41 
2,000 72 23 
2,000 81 21 
2,000 57 17 
6,000 85 13 
300 89 53 80 84 84 79 63 
+ + 
B Lymphoid Lineage 
3,000 79 12 78 69 29 15 12 
6,000 82 18 42 27 22 
600 73 46 51 
15,000 66 20 45 28 12 
3,000 82 12 
11 ,000 46 13 
4,000 83 13 
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